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Parkinson’s disease (PD) is a neu-
rodegenerative disease that is char-
acterized by motor symptoms. The 
symptoms are currently quantified 
subjectively. In this thesis, novel ap-
proaches were developed for quanti-
fying objectively the neuromuscular 
and motor function in PD by using 
surface electromyography and kin-
ematic measurements. The results 
demonstrate the potential usability 
of these measurements and the de-
veloped feature extraction methods 
in quantifying motor symptoms of 
PD and the effects of treatment. 
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ABSTRACT
Parkinson’s disease (PD) is a progressive neurodegenerative disorder that
is characterized by motor symptoms. The symptoms can be relieved with
medication or with deep brain stimulation (DBS). However, there are well
recognized problems in the diagnostics and treatment of PD. The diag-
nostic accuracy is low, and objective methods for quantifying motor im-
pairment in PD and the effects of treatment are lacking.
Surface electromyography (EMG) and kinematic measurements can
be used for objectively quantifying the neuromuscular and motor function
of humans. Therefore, these measurements may be potentially useful for
quantifying motor symptoms of PD and the effects of treatment. However,
the EMG signals of PD patients are characterized by spikes and bursts that
are not effectively captured with conventional methods of EMG analysis.
Therefore, more novel methods of EMG analysis are needed.
In this thesis, three approaches were developed for discrimination be-
tween PD patients and healthy persons on the basis of isometric or dy-
namic EMG and acceleration measurements. In addition, one approach
was presented for quantifying the effects of DBS treatment on PD pa-
tients. All of the developed approaches were based on an innovative way
to combine a principal component (PC) -based method with the selec-
tion of PD characteristic signal features. Measured EMG and acceleration
signals of different PD patient and control groups were used for analysis.
The results show that it is possible to discriminate between PD pa-
tients and healthy persons on the basis of EMG and acceleration measure-
ments and analysis. The isometric and dynamic approaches are sensitive
to different types of PD. In addition, it is possible to detect DBS- and
medication-induced changes in the EMG and acceleration signal features.
The results indicate that the developed methods are potentially useful for
quantifying motor symptoms of PD and the effects of treatment objec-
tively.
National Library of Medicine Classification: QT 36, WE 500, WE 103, WL 359
Medical Subject Headings: Parkinson Disease/diagnosis; Electromyography;
Biomechanics; Nonlinear Dynamics; Deep Brain Stimulation; Principal Com-
ponent Analysis; Cluster Analysis; Discriminant Analysis
Yleinen suomalainen asiasanasto: Parkinsonin tauti; diagnostiikka; elektromyo-
grafia; biomekaniikka; matemaattiset menetelma¨t
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ABBREVIATIONS
ACC Acceleration
A/D Analog-to-digital
BB Biceps brachii
DBS Deep brain stimulation
EEG Electroencephalogram
EMG Electromyogram
ET Essential tremor
LFP Local field potential
MED Medication
MEG Magnetoencephalogram
MRI Magnetic resonance imaging
MU Motor unit
PC Principal component
PD Parkinson’s disease
PET Positron emission tomography
PSD Power spectral density
RBD REM sleep behavior disorder
REM Rapid eye movement
ROM Range-of-motion
SNR Signal-to-noise-ratio
SPECT Single photon emission computed tomography
SD Standard deviation
STN Subthalamic nucleus
UPDRS Unified Parkinson’s disease rating scale
NOTATIONS
(·)∗ Complex conjugate operator
(·)T Transpose operator
E{·} Expected value
αk Eigenvalue
φk Basis vector, eigenvector
λ Delay parameter
µx Mean of sample values
θ Matrix containing the model weights (PCs)
θˆ Estimate of θ
θj(i) i’th principal component for j’th measurement
σx Standard deviation of sample values
τ Time lag
ψ(t) Wavelet function
a Scale of wavelet function
ARV Average rectified value
b Shift of wavelet function
Cxy( f ) Magnitude squared coherence estimate between x and y
Coh Coherence variable
Cm(r) Correlation sum
CR Crossing rate variable
de(ui, uj) Euclidean distance between vectors ui and uj
dmax(ui, uj) Maximum difference between the components of ui and uj
D2 Correlation dimension
fi Spectral frequency at index i
fs Sampling frequency
H Model matrix
k Kurtosis variable
K Number of eigenvectors for modeling
m Embedding dimension
M Number of measurements
Me Number of epochs
M f Index of the highest harmonic in spectrum
MDF Median frequency
MDFi Index of MDF in PSD estimate
MNF Mean frequency
Ne Epoch length
Nm Number of embedding vectors
Np Number of original parameters
Nx Length of time series x
pj Original signal parameter
Pacc Signal power of acceleration
Pi PSD value at frequency fi
Px( f ) PSD estimate of time series x
Pxy( f ) Cross-spectral estimate between time series x and y
PWx (a, b) Wavelet scalogram of signal x
PWxy(a, b) Wavelet cross-scalogram between signals x and y
r Threshold distance
rxy(τ) Cross-correlation function
RZ Data correlation matrix
%REC Recurrence rate
RMS Root mean square amplitude
S Number of clusters
SampEn Sample entropy
ui Embedding vector
U Window energy
v Matrix containing the model errors
w Window function
Wmax Wavelet variable
Wx(a, b) Continuous wavelet transform of signal x(t)
x Time series
x(j) j’th epoch of signal x
xn Time series value at time index n
x(t) Continuous signal
X( fk) Fourier transform of signal x
zj Feature vector
Z Feature matrix
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1 Introduction
1.1 BACKGROUND OF THIS THESIS
The human motor system controls the posture, force and move-
ments in humans. It consists of the central motor system and a
large number of motor units (MUs) [123]. Each MU consists of a
motoneuron in the spinal cord, the multiple branches of its axon
and the muscle fibers that it innervates [44]. Therefore, there exists
a link between the central nervous system and the skeletal muscles,
which makes the human movements possible. The electrical po-
tential that is caused by the function of muscles is called the elec-
tromyogram (EMG). EMG signal can be measured from muscles
by using intramuscular needle electrodes or by using surface elec-
trodes attached to the skin. The latter method is called the surface
EMG measurement. Conventionally analyzed parameters from the
surface EMG signals are based on amplitude and spectral analysis
and they are used for quantifying the level of muscle activation or
fatigue. During the past decades, there has been a growing interest
for studying human movement and EMG in order to understand
better the control of human movements, and movement disorders
and their treatment [110].
Parkinson’s disease (PD) is a progressive neurodegenerative dis-
ease that affects 1 % of people over 60 years of age in industrial-
ized countries [29]. The basic phenomenon in the genesis of PD is
a dopaminergic neuronal loss in the substantia nigra in the basal
ganglia of the cerebra [96]. There are four primary symptoms of
PD: tremor, rigidity, bradykinesia and postural instability [88]. The
diagnosis of PD is based on the presence of the primary symp-
toms and on the response to anti-parkinsonian medication [88]. Al-
though there is no cure for PD, the symptoms can be relieved rea-
sonably with anti-parkinsonian medication or with a more modern
method, the deep brain stimulation (DBS) [72]. In DBS, high fre-
quency pulses are used to stimulate the subthalamic nucleus (STN)
Feature Extraction Methods for EMG and Kinematic Measurements in PD
and associated brain regions [133]. The motor impairment and the
effects of treatment are clinically evaluated subjectively using stan-
dardized rating scales such as the Unified Parkinson’s disease rat-
ing scale (UPDRS) [45,65]. The standardized rating scales in combi-
nation with the established clinical criteria are currently the golden
standard in the diagnostics of PD and in tracking the disease pro-
gression [122]. However, there are widely recognized problems in
the diagnostics and treatment of PD. The diagnostic accuracy is
low (75 % according to clinicopathological studies in the UK and
Canada and 70 % at the early stages of the disease) [173]. In clinical
use, there are no objectively measured characteristics and methods
for quantifying the disease progression and the efficacy of treatment
in PD [5]. In addition, the pre-motor period of PD before diagnosis
may last 5–20 years and at the time of the diagnosis already 50–60
% of the dopaminergic neurons are lost [111, 157].
Several objective methods have been proposed for improving
the diagnostic accuracy of PD, for enabling earlier diagnosis, and
for quantifying the disease severity, progression and the effects of
treatment. These methods include: motor performance tests, ol-
faction tests, imaging techniques, and biochemical tests of blood
and cerebrospinal fluid. None of the proposed methods is widely
available or clinically used for PD. The validation of the objective
methods takes time and a large number of regulatory requirements
need to be considered before a new instrument can be accepted as
a clinical tool. It is probable that a combination of several methods
will be needed for PD. [5, 40, 122]
It has been observed that the basal ganglia have a specific ef-
fect on the temporal organization of motor cortical activity during
muscle contractions [155]. In this way, the dysfunction of substan-
tia nigra and basal ganglia leads to abnormalities of skeletal mus-
cles (tremor, bradykinesia and rigidity) as observed in PD patients.
The function of skeletal muscles can be quantified by using sur-
face EMG and kinematic measurements. These measurements are
relatively simple, repeatable, non-invasive and cost-effective meth-
ods for quantifying neuromuscular function and movement. A few
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new technologies based on kinematic sensors (Tremorometer by
FlexAble Systems Inc., Mobility Lab by APDM Inc. and KinesiaTM
by Great Lakes Neurotechnologies) have been recently commercial-
ized for measuring motor signs of PD. In this thesis, surface EMG
was combined with kinematic measurements for quantifying motor
symptoms of PD. It is possible that surface EMG provides earlier
or more direct information about PD than the kinematic measures
based on movement.
Surface EMG and kinematic measurements have been used for
evaluating PD patients in several published studies (see review in
Chapter 4). A large part of the published studies have compared
the EMG and kinematic signal characteristics between PD patients
and healthy persons, and aimed to correlate the most significant
findings with the clinical rating scales. Differences between pa-
tients and healthy persons have been observed in the EMG and
kinematic characteristics of tremor, in the joint kinetics and mus-
cle activation patterns during limb movements, in the parkinsonian
gait characteristics and in the spectral coherence between EMG and
other biosignals. Another part of the published studies have evalu-
ated the effects of treatment (medication and DBS) on PD patients.
It has been observed that medication and DBS may modify the
tremor characteristics, movement speed, EMG burst patterns and
the cortico-muscular coherence. The increasing number of studies
on the topic indicates that there is currently a lot of interest for
characterizing EMG and kinematic measurements of PD patients.
However, most of the published studies have concentrated on an-
alyzing the statistics of single signal parameters on a group level
(patients vs. controls or treatment on vs. treatment off) and by us-
ing only conventional methods of signal analysis. More information
about PD could be extracted from the measurements by using also
more modern methods of signal analysis, by analyzing sets of sig-
nal features and by analyzing the measurements also on individual
level.
EMG signals are impulse-like waveforms because they consist
of MU action potentials. The level of MU synchronization is in-
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creased in PD [53, 176], which appears as an increased number of
recurring spikes and bursts in the EMG signals. Therefore, the im-
portant information about PD is in the morphology of an impulse
chain. The signal parameters that are conventionally used for EMG
analysis (amplitudes and the mean or median frequencies) are not
effective in capturing impulse-like structures [116]. Therefore, spe-
cific methods based on signal morphology, nonlinear dynamics and
wavelets were proposed and used for quantifying the EMG signals
of PD patients on individual level in this thesis.
1.2 SCOPE AND STRUCTURE OF THIS THESIS
Parkinson’s disease is characterized by motor symptoms. The hy-
potheses of this thesis included that:
• surface EMG signal features are sensitive to PD
• kinematic signal features are sensitive to PD
• the effects of PD treatment (DBS or medication) can be de-
tected in the EMG and kinematic signal features
If the hypotheses are true, it becomes possible to discriminate be-
tween PD patients and healthy persons and to quantify the effects
of treatment on the basis of EMG and kinematic measurements. It
is hoped that the results of this thesis can help in creating a practi-
cal method for quantifying motor symptoms of PD and the effects
of treatment on individual PD patients.
The aim of the thesis was to develop methods of surface EMG
and kinematic analysis for discriminating between PD patients and
healthy persons, for quantifying the motor impairment in PD, and
for quantifying the effects of treatment. The methodological aims
of each study were following:
• In the study I, the aim was to quantify the morphology of
EMG signals in PD compared to healthy subjects by using
statistical information.
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• In the studies II and III, the aim was to extract effective EMG
and acceleration (ACC) signal features for discriminating in-
dividual PD patients from healthy controls on the basis of iso-
metric (study II) or dynamic muscle contractions (study III).
• In the study IV, the aim was to extract sensitive signal features
for detecting DBS-induced changes in the signal characteris-
tics of PD patients.
• In each study I-IV, the aim was to develop an innovative
approach, that combines a principal component (PC) -based
method with the set of signal features, for analyzing the EMG
and acceleration signals in PD.
It was observed in this thesis that specific parameters based on
signal morphology, nonlinear dynamics, spectral coherence and
wavelets were the most effective methods for analysis.
For method development, EMG and kinematic measurements of
PD patients and healthy controls were carried out in eight measure-
ment places consisting of hospitals, universities and research units
in four different countries (Finland, Russia, USA and China). The
measurement data of 62 PD patients and 72 healthy controls from
six measurement places in Finland, Russia and USA were used in
this thesis. The measurement protocol was chosen as simple and
repeatable, because it was important to get comparable and reli-
able results from several measurement places. The patients were
in different stages of the disease and they were measured during
different states of the treatment.
This thesis consists of seven chapters. Chapters 2 and 3 give
background information about electromyography, kinematics of
human movement and Parkinson’s disease. Chapter 4 is a review of
the studies that have used EMG and kinematic measurements for
quantifying motor impairment in PD and the effects of PD treat-
ment. Chapter 5 describes the EMG and kinematic measurements
and the methods of signal analysis in the studies I-IV. Chapter 6
presents the main results and Chapter 7 contains a discussion and
conclusions.
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2 Skeletal muscle function
and surface EMG
2.1 HUMAN MOTOR CONTROL
The human motor system (see [123] for a detailed description) con-
trols the posture, force and movements in humans. It consists of
the central motor system and a large number of motor units. The
schematic structure of the motor system is presented in Fig. 2.1.
Several cortical parts of the cerebra participate in motor program-
ming. These parts include: the premotor cortex, the supplementary
motor area, and the associated areas of the cortex. The inputs from
these areas, from the cerebellum and from the basal ganglia affect
the neurons of the primary motor cortex. The outputs from the
primary motor cortex control the inter-neurons and motoneurons
in the brain stem and in the spinal cord. Each motoneuron inner-
vates certain muscle fibers in the skeletal muscles via the peripheral
nerve [44]. This provides a direct cortical control of muscle activ-
ity [123].
A motor unit is a basic unit of the neuromuscular system. It
consists of a motoneuron, multiple branches of its axon, and the
muscle fibers that it innervates [44]. Most skeletal muscles consist
of few hundred MUs [44].
In voluntary muscle contraction, a nerve impulse reaches the
end of the nerve fiber and a neurotransmitter (acetylcholine) is re-
leased into the motor end plate of the muscle [130]. This leads
to the generation of an MU action potential, a chemical reaction in-
side the muscle fiber and eventually to the contraction of the muscle
fiber [130]. The muscle force is modulated by the number of MUs
recruited and the recruiting frequency [123].
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Figure 2.1: Motor system.
2.2 MEASUREMENT AND ANALYSIS OF HUMAN MOVE-
MENT
In this thesis, arm movements were measured and analyzed dur-
ing isometric and dynamic muscle contractions. This section gives
background information about the measurement and analysis of
human movement that is necessary for understanding the used
methods in the studies I-IV and in the reviewed studies in Chapter
4.
The basic concepts in the study of human movements are the
biomechanics, the kinematics and the kinetics. Biomechanics stud-
ies the biological systems by applying the principles of mechan-
ics [44]. Kinetics and kinematics are branches of biomechanics that
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study human movement and differ from each other with their rela-
tion to the causes of motion (i.e. forces). Kinetics studies forces and
moments exerted on the body, but kinematics ignores the forces
[44].
The human movement can be described by using the terms of
position, velocity and acceleration [44]. The movements and the
forces that cause the movement can be measured by using various
sensors such as the accelerometers, goniometers, inclinometers, and
force and torque sensors. The sensors are based for example on
mechanical, optical or inertial sensor technologies [26]. Possibly
the most common registration methods for human movement are
based on cameras [26, 110].
In camera-based systems one or multiple camera units are used
for detecting the positions of light reflectors or emitters that are
placed at the key points of the human body [26]. The three-
dimensional coordinates of the reflective targets are reconstructed
from multiple camera images. By analyzing the coordinates as a
function of time, it is possible to calculate parameters that describe
the movement. In several studies, a camera-based system has been
used for measuring movement and especially gait in PD patients.
Gait has been, in fact, one of the most commonly analyzed tasks in
the kinematic studies of PD (see review in Chapter 4). Typically an-
alyzed gait characteristics include spatiotemporal gait parameters
(e.g. stride length, gait speed and stance time) and the ranges-of-
motion (ROMs) for the hip, knee and ankle joints. Force plates
or in-shoe pressure measurement systems can provide information
about ground reaction forces during gait.
Human movements can be measured and analyzed during non-
dynamic or dynamic muscle contractions. The non-dynamic mus-
cle contractions are called in this thesis as isometric muscle con-
tractions, in which the length of the muscle, the posture and the
force produced by the muscle are apparently constant. Actu-
ally, only involuntary movements (such as the tremor) are present.
Therefore, these measurements are suitable for analyzing tremor.
The dynamic muscle contractions, instead, include varying pos-
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ture and force produced by the muscles [48]. From the dynamic
muscle contractions it is possible to analyze movement amplitudes
and speeds, frequencies of repetitive movements, and also reaction
times. In kinetic studies, joint angles and torques are often ana-
lyzed [43, 153, 188, 189].
2.3 EMG SIGNAL GENERATION AND MEASUREMENT
Each time a motoneuron is activated by the central nervous system,
it elicits one or more action potentials in all of its muscle fibers [44].
The EMG signal is generated by the electrical activity of the muscle
fibers that are active during a muscle contraction [51]. It is the
sum of all MU action potentials at a given location [130] and can
be detected by using electrodes inside of a muscle (intramuscular
EMG), under the skin over the muscle (subcutaneous EMG) or on
the skin surface over the muscle (surface EMG) [44]. This thesis
deals with the surface EMG signal (see example in Fig. 2.2).
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Figure 2.2: Surface EMG signal measured from biceps brachii muscle during four elbow
flexion-extension movements.
Surface EMG can be measured by using a bipolar or monopolar
recording connection (see [44] for reference). In monopolar connec-
tion, one recording electrode and one ground electrode are used.
The measured signal is the voltage between the recording electrode
and the ground electrode. In bipolar connection, two recording
electrodes and one ground electrode are used. The measured signal
is determined in two steps (see Fig. 2.3). First, the voltage between
each recording electrode and the ground electrode is defined. Then
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the difference between the two voltages is calculated and ampli-
fied. The benefit of bipolar recording connection is that the noise,
that is similar for both voltages, is eliminated. The resulting signal
(voltage as a function of time) is called the surface EMG.
Figure 2.3: Formation of surface EMG signal in bipolar connection. V1 and V2 are the
voltages between the recording electrodes and the ground (Vground). A is the gain of the
differential amplifier.
There are recommendations for surface EMG measurement
equipment and processing. Probably the most recognized Euro-
pean recommendations for the surface EMG electrodes, electrode
placement, signal processing and modeling have been developed
during years 1996–1999 in a large SENIAM project [62, 80]. SE-
NIAM recommends to use pre-gelled Ag/AgCl electrodes in bipo-
lar connection by placing them 20 mm from each other [63]. The
inter-electrode distance affects on the pick-up area of the MU activ-
ity and on the information gained from the muscle. Therefore, also
larger inter-electrode distances have been recommended [47]. Too
large inter-electrode distance, however, may lead to cross-talk from
other muscles [63]. Because different electrode locations provide
signals with different features, one should report the placement of
electrodes in all EMG studies [51]. In order to study the behavior
of individual MUS, there has been recent interest for developing
measurement techniques (electrode arrays) for high-density surface
EMG [120].
The EMG signal is sampled by reading its instantaneous val-
ues at specific time instants and converted into binary values by
using an analog-to-digital (A/D) converter. The Nyquist theorem
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requires that the signal is sampled at the frequency that is twice
the frequency of its highest harmonic of interest in order to avoid
losing important information and distortion of spectrum (aliasing
effect) [119]. About 95 % of the EMG signal power is below 400 Hz
frequency and the remaining 5 % is mainly electrode and equip-
ment noise [118]. Thus, it is recommended to low-pass filter the
EMG with 500 Hz cut-off frequency (sampling frequency > 1000
Hz) [118].
The surface EMG signal is a sum of MU action potentials and
therefore its pattern is an impulse-like waveform. After filtering
the signal may look like a random noise with a Gaussian distribu-
tion function in healthy subjects [174]. However, the morphology
of EMG signals can reveal information about neuromuscular disor-
ders (see study I). The peak energy of the EMG spectrum is in the
frequency range 30–150 Hz [174] and the amplitude of the signal in
the range 0–10 mV [144]. EMG signals are often affected by noise.
Different noise types include: electronic noise from other equip-
ment, ambient noise (electromagnetic radiation), motion artifacts
and inherent instability (the firing rate of the MUs is instable) [144].
Slow variations (frequency 0–20 Hz) in the surface EMG signal
can be caused by movement and by the instability at the electrode-
skin interface [118]. If one is interested in the firing rates of the
active MUs, one should be careful in handling the low frequency
components [118]. If one is interested only in the EMG amplitude,
instead, the removal of the low frequency components is preferred
[144]. The removal of low frequency components from the EMG can
be done by high-pass filtering the EMG signal with an appropriate
high-pass filter or by using a trend removal method such as the
smoothness priors method [170].
2.4 CONVENTIONAL SURFACE EMG ANALYSIS AND AP-
PLICATIONS
Conventionally analyzed parameters from the surface EMG signals
are based on amplitude and spectral analysis. Amplitude-based
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methods can be used for quantifying the level of muscle activation
and fatigue, and spectral-based methods for quantifying muscle fa-
tigue [23]. In this section, the most commonly used EMG parame-
ters are presented.
Several things affect the amplitude of the surface EMG signal:
the thickness and conductivity of the skin and subcutaneous lay-
ers, the relative position between electrodes and the innervation
zones and tendons of the active MUs, and the properties of the
electrodes [118]. The most commonly used amplitude indicators
are the average rectified value (ARV) and the root mean square
value (RMS) defined over an epoch with length Ne [50]. ARV can
be calculated in its discrete form as follows:
ARV =
1
Ne
Ne
∑
n=1
|xn|, (2.1)
where xn is the EMG signal value at time index n. RMS can be
calculated in its discrete form as follows:
RMS =
√√√√ 1
Ne
Ne
∑
n=1
x2n. (2.2)
The recommended epoch duration is 1–2 seconds for low and
0.25–0.5 seconds for high contraction levels of isometric contrac-
tion [118]. Sample decorrelation by using a whitening filter is
recommended before amplitude estimation when a high signal-to-
noise-ratio (SNR) is important [118]. In dynamic contractions, the
amplitude estimation is performed by calculating the ARV or RMS
value with a sliding window or by calculating the envelope of EMG
by rectifying and low-pass-filtering the signal [48]. Ensemble aver-
aging is recommended in the dynamic amplitude analysis in order
to reduce the estimation error [118].
In spectral analysis, the aim is to present the signal in the
frequency-domain by estimating its power spectral density (PSD)
(see Fig. 2.4). The most common approaches for EMG spectral esti-
mation are the Fourier approach and the parametric approach [118].
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The Fourier approach is described briefly in section 5.2.1 and more
detailed theories of these approaches can be found in [2, 143].
The most commonly used frequency descriptors of EMG are the
mean frequency (MNF) and the median frequency (MDF) [50] that
can be calculated from the equations:
MNF =
∑
M f
i=1 fiPi
∑
M f
i=1 Pi
(2.3)
MDFi
∑
i=1
Pi =
M f
∑
i=MDFi
Pi =
1
2
M f
∑
i=1
Pi, (2.4)
where Pi is the PSD value at frequency fi, and M f is the index of
the highest harmonic and MDFi the index of MDF. An example
of EMG power spectrum and the corresponding MNF and MDF
parameters are presented in Fig. 2.4.
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Figure 2.4: EMG power spectrum, mean and median frequencies.
Another commonly analyzed EMG parameter is the muscle
fiber conduction velocity. It can be estimated as the ratio between
the inter-electrode distance and a propagation delay [118], and it
can provide information about physio-pathological conditions [50].
The applications of surface EMG include movement and gait
analysis, rehabilitation, ergonomics, prosthesis control and exercise
physiology. In movement analysis, EMG can be used for study-
ing motor control strategies and mechanisms of muscle contraction,
and for identifying pathophysiologic factors [64]. In rehabilitation,
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EMG can be used for detecting changes in muscles, and in the re-
cruitment and coordination of muscle activity [141]. In ergonomics,
amplitude- and spectral-based parameters of EMG can be used for
quantifying muscle load and fatigue during work at certain work
positions [75]. In prosthesis control, the measured EMG signal can
be used for modulating the function of a prosthesis [132]. In exer-
cise physiology, EMG can be used for studying adaptations of the
neuromuscular system to heavy resistance training and the time
course of these changes [55].
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3 Parkinson’s disease
3.1 EPIDEMIOLOGY AND NEURAL PATHOPHYSIOLOGY
Parkinson’s disease is a progressive neurodegenerative disorder
that affects 0.3 % of the total population and 1 % of people over
60 years of age in industrialized countries [29]. The number of new
PD cases per year is 8–18 per 100 000 persons [29]. In south-western
Finland, there were 166 PD patients per 100 000 persons in year 1992
and the number of new patients per year was 15 per 100 000 per-
sons [102]. The number of patients increases with the increasing age
and the average age of the onset of symptoms is approximately 60
years [72]. If the current trend of population aging continues, the
number of PD patients will increase significantly during the next
two decades [39].
A detailed description of the neural pathophysiology of PD can
be found in [187]. Briefly, the basic phenomenon in the genesis of
PD is a dopaminergic neuronal loss in the substantia nigra in the
basal ganglia of the cerebra [96]. Specific inclusion bodies (Lewy
bodies) can be observed inside the degenerating neurons [96]. The
dopaminergic neurons control the function of the extrapyramidal
system that processes the movement information from the cortex to
the striatum and returns it through the thalamus back to the cortex
[96]. In PD, the control of the extrapyramidal system is disturbed
and the feedback from the striatum to the cortex is modified [96].
The abnormalities in the function of basal ganglia lead to the motor
symptoms of PD [187].
Although the exact cause of PD is still unknown, some risk fac-
tors have been identified [72]. The risk factors include genetic and
environmental risk factors (toxins, viruses and unhealthy food) [97].
The two most important risk factors are an increasing age and a
positive family history of PD (in 15–20 % of cases) [72]. Although
PD by itself is not fatal, it leads to physical deficits that predispose
to certain diseases (e.g. pneumonia), falls and resulting complica-
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tions [142].
3.2 SYMPTOMS AND CLINICAL DIAGNOSIS
There are four primary symptoms of PD: tremor, rigidity, bradyki-
nesia and postural instability [88]. Tremor is the most visible symp-
tom of PD. It means involuntary, rhythmic and oscillatory move-
ments of body parts and it affects 80–90 % of PD patients [72]. The
parkinsonian tremor occurs most commonly during a resting con-
dition, but it may appear also during postural, kinetic or intention
condition [121].
Bradykinesia and rigidity are parkinsonian symptoms that can
be observed during or prior to movement. Bradykinesia means the
slowness of movement and it includes difficulties with planning,
initiating and executing movements [88]. It has been estimated
that 77–98 % of PD patients suffer from bradykinesia [68]. Rigid-
ity, instead, is an involuntary increase in the muscle tone [72] and
it affects 89–99 % of PD patients [68]. It appears as an increased
resistance to passive movements of the limb [88].
At the advanced stages of the disease, many patients suffer from
postural instability [88] and non-motor symptoms of PD [173]. The
postural instability appears as a poor balance, unsteadiness, and
falls [72]. The non-motor symptoms of PD include: dementia, de-
pression, psychotic features (e.g. hallucinations), autonomic dys-
function and oculomotor abnormalities [68]. The progression of PD
is individual [72].
The diagnosis of PD is based on the presence of clinical symp-
toms and on the response to anti-parkinsonian medication [88]. The
diagnostic accuracy is 75 % according to clinicopathological stud-
ies from the UK and Canada, and can be as low as 70 % at the
early stages of the disease [173]. In specialized units, the diagnostic
accuracy can be higher [72]. Several diagnostic criteria have been
provided for increasing the diagnostic accuracy [68, 72, 88]. In the
criteria, the symptoms have been divided into inclusionary and ex-
clusionary symptoms. The diagnosis requires that two of the four
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primary symptoms are present [68, 88, 164].
A significant reason for the low diagnostic accuracy is formed
by other diseases with similar symptoms than PD [173]. One
of these diseases is the essential tremor (ET), which is ten times
more common than PD and often confused with PD [72]. Other
PD like disorders include: multiple system atrophy, progressive
supranuclear palsy, corticobasal degeneration and Lewy body de-
mentia [129]. Imaging techniques, such as the positron emission
tomography (PET), single photon emission computed tomography
(SPECT) and magnetic resonance imaging (MRI), can help to some
extent in differentiating PD from other similar diseases [173]. How-
ever, the imaging methods are costly and some of them are not
widely available [68]. Their usefulness in clinical practice has been
debated such as in [42].
3.3 TREATMENT
Although there is no cure for PD, the symptoms can be relieved
reasonably with medication that aims either to increase the amount
or to inhibit the breakdown of dopamine in the brain [67,72]. There
are different types of drugs available for reducing motor symptoms
of PD and the most effective of them is the levodopa [67, 72]. The
dose and combination of drugs are set individually. A long-term
use of levodopa leads often to motor complications (wearing off,
involuntary movements and on/off-effect) [72].
Deep brain stimulation is another treatment method for PD. It
has replaced the ablative stereotactic surgery in the treatment of
PD [181] and it has become a preferred surgical treatment method
for advanced PD [10]. DBS is effective in reducing tremor, bradyki-
nesia and rigidity in PD, and it allows for a reduction in the anti-
parkinsonian medication doses [10]. In DBS, high frequency pulses
are used to stimulate the STN (or the internal segment of globus
pallidus) and associated brain regions [133]. The DBS device (see
Fig. 3.1) consists of an implanted pulse generator (placed in a sub-
cutaneous pocket below the clavicle), a connecting wire, and one
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or two leads with electrode contacts (placed in the STN or globus
pallidus) [72]. Unilateral or bilateral stimulation techniques (stimu-
lation of one or both sides of the brain) are possible [72]. The exact
mechanisms of the action of DBS are still unclear [10]. The success
of DBS treatment depends strongly on the exact locations of the
stimulation electrodes, on the settings of the stimulation param-
eters (electrode polarity, stimulation amplitude, pulse width and
stimulation frequency) and on biological factors [181].
Figure 3.1: Unilateral deep brain stimulation. Figure is from D. Grosset, K. Grosset,
M. Okun, and H. Fernandez, ”Parkinson’s disease - Clinician’s desk reference” (Manson
Publishing Ltd., London, 2009).
3.4 CLINICAL RATING SCALES
The motor impairment and the efficacy of treatment in PD are of-
ten evaluated using standardized rating scales [65]. The used scales
include the Unified Parkinson’s disease rating scale [45], the Hoehn
and Yahr staging scale, the Schwab and England functional assess-
ment scale and a set of validated tests [5]. The most widely used
clinical rating scale is the UPDRS [69], which consists of four parts:
I) Mentation, Behavior and Mood, II) Activities of Daily Living,
III) Motor Examination and IV) Complications of Therapy [65]. It
has been criticized that the currently used UPDRS is confusing for
capturing non-motor elements of PD and therefore the Movement
20 Dissertations in Forestry and Natural Sciences No 62
Parkinson’s disease
Disorder Society has sponsored a revision of the UPDRS [69].
The motor examination section of the UPDRS [45] can be used
for scoring numerically the severity of most significant motor symp-
toms of PD. In that examination, tremor is tested during a resting
condition, in a postural condition of the arms and during move-
ment. The rigidity is assessed by passively moving the major joints,
and bradykinesia by observing patient’s walking, face and voice,
and testing hand, arm and leg movements. In general, PD patients
tend to walk with short steps, by dragging of one leg and with
reduced arm swing [72]. The spontaneous movements, gesturing
and facial expression are commonly lost in PD [88]. The repetitive
movements (finger-taps with index finger and thumb, open-close
movements of hands and pronation-supination movements at the
wrist) are slower and of lower amplitude in PD patients than in
healthy persons. Arrests in movement are common [72].
3.5 PROBLEMS AND FUTURE ASPECTS
The established clinical diagnostic criteria in combination with the
clinical rating scales are currently the golden standard in the diag-
nostics of PD and in tracking the disease progression [122]. How-
ever, there are widely recognized problems in the diagnostics and
treatment of PD. The diagnostic accuracy is low and there are no
objectively measured characteristics and methods (i.e. biomarkers)
for following the disease progression and for quantifying the effi-
cacy of treatment in PD [5]. In addition, at the time of the diagnosis
already 50–60 % of the dopaminergic neurons are lost [111]. The
premotor period before the motor symptoms of PD may last 5–20
years [111, 157].
Several potential biomarkers have been proposed for PD. These
objective methods include: motor performance tests, oculomotor
measurements, olfaction tests, neurophysiological measurements,
imaging techniques (e.g. MRI, SPECT and PET), biochemical mea-
surements (e.g. blood tests), evaluation of rapid eye movement
(REM) sleep behavior disorder and genetic tests [5,122]. All of them
Dissertations in Forestry and Natural Sciences No 62 21
Feature Extraction Methods for EMG and Kinematic Measurements in PD
have their own advantages and disadvantages regarding the sen-
sitivity, usability and the cost-effectiveness of the method [5, 122].
Although much progress has been made in identifying and evaluat-
ing biomarkers for PD, none of them is widely available or clinically
used for PD. The validation of the biomarkers takes time and a large
number of regulatory requirements need to be considered before a
new method can be accepted as a clinical tool. It is probable that a
combination of several biomarkers will be needed for PD. [5,40,122]
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4 EMG and kinematic studies
on PD
During the past ten years there has been a growing interest in using
EMG and kinematic measurements for studying PD and its treat-
ment, which can be seen as an increasing number of publications on
the topic. According to PubMed database (United States National
Library of Medicine, National Institute of Health), there are approx-
imately 180 published studies that have analyzed EMG or kinemat-
ics in PD patients during years 2000–2010. This chapter contains a
brief review on a selected portion of these studies by concentrat-
ing on the studies using EMG (see Table 4.1) and the main findings
from them. The studies have been divided here into six categories:
1) studies on tremor, 2) studies on rigidity, 3) studies on bradyki-
nesia and movement, 4) studies on REM sleep, 5) studies on gait,
turning and translations, and 6) studies on the spectral coherence
between EMG and other biosignals.
4.1 STUDIES ON TREMOR
The parkinsonian tremor appears typically during a resting con-
dition with a frequency between 3–5 Hz [156]. Another type of
parkinsonian tremor is a postural tremor in the frequency range
5–12 Hz [176]. The parkinsonian tremor characteristics have been
studied by using EMG measurements. It was suggested in [121]
that the parkinsonian tremors can be divided into four categories
on the basis of postural tremor occurrence and frequency, and on
the basis of EMG burst characteristics (burst amplitude, burst du-
ration and synchronization of bursts). Kinetic tremors have also
been measured from PD patients during tracking movements of
the arm in [11]. In [153], it was found that the proportion of EMG
power correlated positively in the frequency band 5–15 Hz and neg-
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Table 4.1: Study categories, studies and examples of analyzed parameters.
Study category Studies Example parameters
Tremor [11, 13, 15, 16, 91, 113, 114,
116, 121, 137, 153, 162, 163,
176, 179]
tremor occurrence, am-
plitude and frequency,
tremor-EMG coherence,
EMG burst occurrence
and synchronization
Rigidity [17,43,73,91,107,113,114,
116, 153, 188, 189, 191]
EMG amplitude, inte-
grated EMG, joint-torque
vs. joint-angle
Bradykinesia and
movement
[9, 18, 22, 27, 30, 31, 52, 61,
79, 101, 134, 135, 150–152,
160, 161, 167, 171, 175, 177,
178]
EMG amplitude and
burst pattern during
movement, peak velocity
and acceleration of move-
ment, amplitude and
frequency of repetitive
movements, reaction time
REM sleep [14, 28, 66, 99, 138] occurrence of phasic and
tonic twitching activity
in EMG, tremor activity
during REM sleep
Gait, turning and
translations
[6,8,9,12,19–21,25,32,37,
46, 57–59, 78, 81, 89, 94, 95,
99, 100, 103, 109, 117, 125–
127, 136, 149, 154, 165, 167,
186, 190]
turning time and number
of required steps, muscle
activation patterns dur-
ing turning, translation,
gait and prior to freez-
ing of gait, gait speed,
stride length, arm and leg
swing, ROM of the lower-
limb joints
Coherence between
EMG and other
biosignals
[4, 112, 131, 140, 145, 146,
155]
coherence at different fre-
quency bands
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atively in the band 15–30 Hz with the severity of PD (UPDRS -motor
score). The mean and median frequencies of EMG, instead, did
not differ between PD patients and healthy controls significantly
in [113,114, 116].
Tremor-EMG coherence has been quantified from simultaneous
EMG and acceleration recordings. In [176], it was observed that the
tremor-EMG coherence was increased in the low frequencies (8–12
Hz) in PD patients when compared to healthy subjects.
The typical EMG recording of tremor contains perfectly alter-
nating EMG bursts [179]. In [92], a method was presented for EMG
burst detection using a second order moment function and the oc-
currence of bursts was analyzed by using inter-burst histograms.
The function of this method was demonstrated with few EMGmea-
surements.
Parkinsonian tremor was compared to the essential tremor in
[15, 16]. It was shown that the parkinsonian tremor consists of a
larger load-independent component and a smaller load-dependent
component in the EMG than the ET [16]. Long-term EMG record-
ings in [15] revealed that the ET and the parkinsonian tremor can be
differentiated between each other by analyzing the mean frequency,
the occurrence and the phase of tremor.
It has been observed that the treatment of PD with anti-
parkinsonian medication or with DBS may modify the tremor char-
acteristics in several ways. Acceleration measurements have proven
to be sensitive in measuring tremor in PD patients with DBS [91].
The EMG measurements have been used for quantifying the effects
of treatment on the tremor frequency in PD. In [13, 162, 163], the
amplitude of tremor was decreased and in [162, 163] the regularity
of tremor was decreased with medication or with DBS. DBS was
more effective in reducing the amplitude, but it did not normal-
ize the tremor regularity [162, 163]. The dominant frequency of
tremor in the EMG spectrum was increased with DBS or with med-
ication in [13, 162, 163]. The tremor-EMG coherence was decreased
with DBS or with medication in [162, 163]. DBS was more effective
in increasing the dominant frequency, but it did not normalize the
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tremor-EMG coherence [162,163]. In [137], the occurrence of tremor
was decreased with medication.
4.2 STUDIES ON RIGIDITY
Rigidity describes the increased muscle tone and it is one of the
primary symptoms of PD [179]. The increased muscle tone has
been studied by using methods based on EMG amplitude and joint
torque vs. joint angle measurements. It was observed in [17, 73]
that the EMG amplitude and the integrated EMG were higher in
PD patients than in healthy subjects during a resting condition but
not during a sub-maximal loading condition or maximal voluntary
muscle contraction [113,114,116]. In [17], the integrated EMG corre-
lated significantly with the clinical rigidity scores. The EMG activ-
ity was increased also in [107] during the middle and late stretching
phase of the elbow flexion-extension movements. In [191], an ab-
normal recruitment of MUs in the laryngeal EMG recordings was
connected with rigidity in PD.
The joint-torque measurements in [153] revealed an increased
relaxation time of torque after releasing the upper arm from con-
traction. This finding correlated positively with the UPDRS -motor
score. In [43], a method was presented for analyzing the rigidity
in PD on the basis of joint torque and EMG measurements. In the
method, an index was calculated as the ratio between passive flex-
ion and extension from the integrated EMG. The difference in the
torque-angle data between flexion and extension was estimated by
calculating a parameter called the sum of the difference of bias.
Both of these parameters correlated significantly with the clinical
rigidity scores. In [189], the rigidity was quantified by integrating
the joint torque with the joint angle and the EMG ratio was calcu-
lated from the normalized mean EMG activity in stretched to short-
ened muscles. It was observed that the calculated rigidity scores
correlated with the EMG ratios strongest during the extension at
high speeds with medication off.
The effects of anti-parkinsonian medication on the rigidity have
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been studied by using EMG and joint torque-angle measurements
[188,189]. In [91], the rigidity was assessed from the EMG by calcu-
lating the amplitude and the inter-burst amplitude of EMG during
a clinical rigidity testing. In [188], it was observed that the nor-
malized EMG activity reduced and the torque-angle slope became
steeper with medication during passive wrist flexion-extension
movements. A strong correlation existed between the normalized
EMG activity and the torque-angle slope with medication off [188].
4.3 STUDIES ON BRADYKINESIA AND MOVEMENT
Several EMG and kinematic studies have examined ballistic move-
ments of the arm in PD patients. In [18], the amplitude of the
agonist EMG during these movements correlated strongly and pos-
itively with the peak velocity and acceleration of the movement. In
the same study [18], half of the patients showed tremor bursts with
the frequency 8–14 Hz and were bradykinetic with respect to con-
trols. A wavelet-based study on the ballistic movements showed
that it was possible to classify PD patients from healthy controls
and to follow the temporal evolution of the disease level by analyz-
ing the integral of the EMG wavelet power [30].
The rapid point-to-point movements of the arm are connected
with several EMG burst abnormalities in PD [52] and many studies
have analyzed these abnormalities in comparison to healthy sub-
jects. In healthy subjects, these movements are connected with
a triphasic EMG burst pattern with alternating agonist-antagonist
bursts [134]. The EMG bursts are normally modulated with changes
in movement distance, speed and loading condition [134]. In PD
patients, an increased number of agonist bursts was observed dur-
ing these movements in [52, 134]. The number of bursts reflected
the disease severity [52] and it was not reduced with practice de-
spite of increase in the peak velocity of the movements [61]. In
severely impaired patients, the scaling of the agonist EMG magni-
tude was reduced and the temporal overlap of the antagonist and
agonist signals was increased [134]. In [152], it was observed that
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the variability of EMG burst measures distinguished PD patients
from healthy controls and correlated significantly with the UPDRS
-motor scores.
When rapid point-to-point movements were compared with the
reversal movements (movements to a target and immediately back
to the starting position) it appeared that in PD patients the flexor
and extensor EMGs were smaller during the reversal movements
while in the healthy older subjects they were modulated in the same
way for both of the movements [135]. In [150], it was observed that
the extension movements of PD patients were slower and associated
with more agonist bursts when compared to flexion movements.
No significant differences were found in the kinematic and EMG
parameters between those movements in healthy controls.
Mirror movements (simultaneous contralateral and involuntary
movements) and movement trajectories have also been analyzed in
PD. A larger mirror-like increase was observed in the EMG during
thumb abduction in PD patients than in healthy young or old con-
trols [22]. In [31], it was observed that the slowness of multi-joint
movements in PD was not associated with changes in the move-
ment trajectory, but it was associated with the reduction of EMG
activity.
In the clinical UPDRS -examination, the severity of bradykinesia
is evaluated by performing repetitive movements of the finger and
hand. Similar movements have been quantified by making kine-
matic measurements as well. In [79], finger tapping, hand grasp-
ing and pronation-supination movements of the hand were stud-
ied. It was observed that kinematic measurements could capture
features of bradykinesia (movement speed, amplitude and rhythm)
that were proposed for more accurate clinical evaluation of bradyki-
nesia in [79]. During repetitive finger movements in [160], PD pa-
tients showed a reduction in the movement amplitude, an increase
in the movement frequency and a loss of phase when the movement
frequency reached or exceeded 2 Hz. All controls could synchro-
nize up to 3 Hz. It was observed in [159] that the rate-dependent
impairments in the repetitive finger movements were not due to
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muscle fatigue in PD patients.
Several kinematic studies have examined the effects of treatment
on the movement speed in PD. The movement speed was increased
with DBS or with medication during the flexion-extension of the
elbow in [151, 161, 177], during the flexion-extension of the ankle
in [178], during the hand rotation in [167], during the horizontal
pointing in [27], during the handwriting in [175] and during the
reaching tasks in [9]. During complex reach-to-grasp tasks in [27],
the bradykinesia was improved for the grasp component. Despite
of combined DBS and medication, the movement speed was not
normalized in [177,178].
The effects of DBS treatment on the reaction time were examined
by measuring EMG and movement in [101]. It was shown that the
latencies of EMG and movement were decreased with DBS during
the simple and choice reaction time tasks. The reaction time was
decreased with DBS also in [171].
The EMG burst characteristics related to movement may be
modified by the treatment of PD as well. It was observed in
[151, 177, 178] that the amplitude and duration of the first ago-
nist burst were increased with DBS or with medication during the
flexion-extension movements of the elbow and ankle. Other results
regarding the EMG burst characteristics are contradictory. In [151],
the agonist burst duration modulation was not restored with move-
ment distance, the burst frequency was not changed and the tim-
ing of the antagonist activation was not altered with medication.
In [177, 178], instead, the amplitude of the antagonist burst was in-
creased, and the number of agonist bursts and the center time of the
antagonist burst were reduced with DBS or with medication. When
medication and DBS were combined in [177,178], the burst duration
and the burst number were further improved, but the EMG was not
normalized.
In [161], wavelets were used for studying the effects of medica-
tion on the EMG signals during elbow movement. In that study, an
index was calculated from the EMG cross-correlation spectrum for
describing the whole cross-correlation energy. It was observed that
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the calculated indexes of patients shifted towards the control values
with medication.
4.4 STUDIES ON REM SLEEP
The connection between the REM sleep behavior disorder (RBD)
and PD has been analyzed in several EMG-based studies [14,66,99,
138]. It has been suggested that RBD can predict for later develop-
ment of PD [14, 138]. The disorder is connected with an increased
muscle tone and limb movements during the REM sleep, and can be
quantified by analyzing the tonic and phasic muscle activity [115].
In [138], it was observed that the tonic EMG activity was in-
creased in RBD patients that developed later PD when compared
to the RBD patients that did not. In the phasic EMG activity there
were no significant differences between these patient groups [138].
In [14], higher percentages of phasic muscle activity were observed
in patients with symmetric PD (motor symptoms in both body
sides) compared to patients with asymmetric PD (motor symptoms
predominantly in one body side), and in patients with akinetic-
rigid PD compared to patients with tremor-predominant PD. The
tremor activity in the EMG was reduced in PD patients during the
REM sleep in [28]. Examination of recently diagnosed untreated
PD patients showed that the untreated patients had a lower phasic
twitching activity compared to controls [66]. The treatment with
levodopa increased both the phasic twitching and the tonic activ-
ity [66].
4.5 STUDIES ON GAIT, TURNING AND TRANSLATIONS
The EMG and kinematic characteristics of turning and multidirec-
tional translations have been studied in PD [19,37,81,99]. It was ob-
served in [19, 81] that PD patients took longer time and more steps
for turning with a delayed re-orientation of the head and with an
altered head-upper trunk rotational strategy. However, the lower
extremity muscle patterns did not differ from the normal muscle
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patterns [81]. The ability of PD patients to adapt the muscle ac-
tivation for narrow and wide translations was studied in [37]. It
was observed that the antagonist muscle activation was earlier and
larger in PD patients and the patients did not increase the magni-
tude of muscle activation as much as controls when changing from
wide to narrow stance.
Many studies have examined the EMG and kinematic charac-
teristics of gait in PD. It was observed in [19–21, 154] that PD pa-
tients walked slower and with reduced arm and leg swing when
compared to controls. During gait, their stride length was shorter
[154,165] and they showed poor braking prior to foot-contact with a
decrease in the leg muscle activity [21]. In addition, the inter-limb
coordination was significantly impaired in PD [20]. It was sug-
gested in [117] that while walking the PD patients are constantly
attempting to align the center of pressure position to the center of
mass position of the body causing the typical pattern of parkinso-
nian gait (walking with quick and short strides).
Freezing of gait is a common motor impairment in PD that
means problems in the initiation and termination of gait, and sud-
den interruptions in walking [127]. In [127], it was observed that
the EMG profiles of gait prior to the onset of freezing were char-
acterized with a premature timing of lower leg muscle activity, a
reduced total amount of EMG activity and an increased amplitude
of EMG bursts. The ROMs of the ankle and hip joints in the sagittal
plane were severely decreased prior to freezing in [126]. In [12], the
PD patients could not increase the muscle activation to same extent
as controls and effectively maintain the stance limb in extension to
decelerate forward motion when they were asked to stop walking.
PD patients typically have an increased risk of falling, which has
been studied by using kinematic measurements. Kinematic analy-
sis of gait in [25] showed that the PD patients, that later fell, moved
their head more mediolaterally relative to walking velocity com-
pared to controls and PD patients that did not fall [25]. In [38],
the possible contributions to falling were examined by measuring
trunk flexion kinematics and movement velocity during standing
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reach movements.
Several studies have examined the effects of treatment on the
gait in PD. It was found in [9, 20, 21, 46, 58, 59, 100, 109, 149, 190] that
the gait speed and the stride or the step length were increased with
DBS or with medication without change in the cadence [46]. The
bilateral stimulation was more effective than the unilateral stimula-
tion in increasing the gait speed and the stride length in [9,167]. By
combining both treatment methods (DBS and medication) the gait
speed and the stride length were further improved [46, 58, 59].
It was observed in [20, 46, 58, 149] that the amplitude of the arm
and leg swing and the ROMs of the lower limb joints were increased
with DBS or with medication. In addition, the phase-shift between
the arm and the ipsilateral leg motion was reduced with DBS or
with medication [20]. The combination of both treatments (DBS
and medication) was able to slightly increase the upper and lower
limb ROMs, but it could not further improve the inter-segmental
coordination [20,58]. In [109], it was observed that the symmetry of
gait was improved with medication or with DBS.
In [57], it was noticed that the EMG profiles of gait were affected
by DBS either by enhancing the main activity bursts or by nor-
malizing the recruitment timing. Unilateral stimulation produced
less consistent EMG changes than the bilateral stimulation. The ef-
fects of PD treatment (DBS or medication) on the gait characteristics
have been studied in [32, 94, 95, 103, 125] as well. In [94], it was ob-
served that the treatment effects on gait and mobility may not be
observed by analyzing gait parameters in the group level although
they would be observable in the individual level of PD patients.
The effects of rehabilitation and the use of assisting technique on
gait and trunk flexion [8] have been studied in PD as well. In [186],
the rehabilitation of PD improved the walking activity and the en-
durance in PD patients. An intensive walking practice in [185] in-
creased the stride length, gait speed and shoulder excursion signif-
icantly. The use of facilitatory insoles in [89] improved the walking
by increasing the single-limb support time and by normalizing the
muscle activation at the time of initial ground contact. In [6,78,136],
32 Dissertations in Forestry and Natural Sciences No 62
EMG and kinematic studies on PD
the rhythmic auditory stimulation increased the stride length and
decreased the stride time in PD patients. The ROMs of the ankle
joint were decreased [136] and the stride-to-stride variability was
decreased [78] in PD patients with rhythmic auditory stimulation.
4.6 COHERENCE BETWEEN EMG AND OTHER BIOSIGNALS
Coherence measures the similarity between two signals as a func-
tion of frequency. Several studies have analyzed the coherence
between EMGs and electroencephalograms (EEGs), local field po-
tentials (LFPs) or magnetoencephalograms (MEG) in PD and com-
pared that to the coherence in healthy subjects. LFPs can be mea-
sured from the brain of PD patients by using implanted DBS elec-
trodes [87]. A significant coherence was observed between LFP
(from the STN and zone inserta) and the EMG (from the contralat-
eral forearm muscles) in the beta frequency band (13–30 Hz) [145]
and a significant tremor-associated coupling was observed at the
tremor and its harmonic frequency in [146]. In [4], the coherence
occurred mainly at the tremor frequency and less in the beta fre-
quency band. The LFP-EMG coherence in the studies [145,146] var-
ied on the LFP localization and the muscle examined. In [140], the
coherence between 64-channel EEG and EMG was measured and
it was observed that the contralateral EEG electrodes with maxi-
mal coherence were different for the basic and the first harmonic
frequency of tremor.
The LFP-EMG-coherence at different frequency bands during
the tonic (isometric contraction of wrist extensors) versus the pha-
sic task (wrist flexion-extension movements) was analyzed in [112].
The observed coherence tended to be higher within the 15–30 Hz
band during the tonic task compared to the phasic task and higher
within the 31–45 Hz band during the phasic task compared to the
tonic task. EMG power and the mean rectified EMG were not sig-
nificantly different between the tasks.
Coherence-based methods have been used for analyzing the ef-
fects of treatment in PD. It was observed in [131] that the cortico-
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muscular coherence between MEG and EMG was significantly
higher with DBS on than with DBS off at the beta frequency band
(13–30 Hz). In [155], the cortico-muscular coherence was lower at
the 15–39 Hz and 35–60 Hz bands in patients with medication off
than with medication on or in healthy controls [155]. Some patients
showed a strong coherence at the 5–12 Hz band with medication
off. It was shown in [155] that the coherent MEG signals originate
from the primary motor cortex that is contralateral to the active
hand.
4.7 CRITICAL REVIEW ON THE LITERATURE
The increasing number of studies on the topic indicates that there
is currently a lot of interest for characterizing EMG and kinematic
measurements of PD patients. However, a comprehensive review
of the studies has been missing. Most of the published studies have
analyzed the statistics of single EMG and kinematic parameters on
a group level (patients vs. controls, MED on vs. MED off, and DBS
on vs. DBS off). The studied patient groups have often been homo-
geneous (the patients have same type of symptoms) and relatively
small (N≤ 15 in 88 % of the reviewed studies). Although significant
group differences have been observed in the single signal parame-
ters, it is probable that a combination of several signal features can
work better in discriminating between the subjects. The analysis on
a group level does not reveal whether the used analysis methods
work effectively on individual patients whose clinical picture can
be quite distinctive.
Most of the published studies have analyzed the EMG signals
of PD patients by using only conventional methods of EMG analy-
sis (mainly amplitude-based methods). However, EMG signals are
impulse-like waveforms and the important information about PD
is in the morphology of an impulse chain. The conventionally used
EMG parameters are not very effective in capturing impulse-like
structures [116]. In this thesis, specific methods based on signal
morphology, nonlinear dynamics and wavelets were used for quan-
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tifying the EMG signals of PD patients on individual level. A novel
PC-based approach in combination with the set of signal features
was applied for analysis.
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5 Materials and methods
5.1 EMG AND KINEMATIC MEASUREMENTS
This thesis consists of four experimental studies (I-IV). The research
material of each study I-IV consists of EMG and kinematic measure-
ment data from a group of PD patients and a group of healthy con-
trols, and the clinical UPDRS -motor examination data from most
of the patients. The measurements, that are analyzed in this thesis,
were performed during years 2006–2010 in the six following places:
Kuopio University Hospital (Kuopio, Finland), Finnish Brain Re-
search and Rehabilitation Center Neuron (Kuopio, Finland), Uni-
versity of Kuopio (Kuopio, Finland), Petrozavodsk State University
(Petrozavodsk, Russian Federation), Beth Israel Deaconess Medical
Center of Harvard Medical School (Boston, USA) and University of
Massachusetts (Worcester, USA).
All measurements were approved by the local Human Ethics
Committee of the Kuopio University Hospital. In addition, the
measurements in Petrozavodsk were approved by the local Hu-
man Ethics Committee of the Petrozavodsk State University and
the measurements in Boston by the IRB Boards of the Beth Israel
Deaconess Medical Center and the University of Massachusetts.
All subjects gave their informed consent before participating in the
measurements.
5.1.1 Subjects
The study protocols (described in section 5.1.2) and the subject
groups in each study I-IV are detailed in Table 5.1. All patients
in the studies I-IV had an earlier diagnosis of idiopathic PD and
they had been prescribed an individual dose and combination of
anti-parkinsonian medications for the condition. The patients did
not have other neurological disorders or injuries that may inter-
fere with the motor function. The patients in the study IV were
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Table 5.1: Study protocols and subjects (N is the number of subjects) in the studies I-IV.
Study Protocol Healthy
controls
Patients
MED on
Patients
MED off
Patients
DBS on
Patients
DBS off
I Isometric N = 22 N = 25 - - -
II Isometric N = 59 N = 42 N = 13 - -
III Dynamic N = 59 N = 49 - - -
IV Isometric
Dynamic
N = 13 - - N = 13 N = 13
having DBS treatment for the condition. The control subjects were
recruited from generally healthy persons.
During the measurements, the medication conditions of the pa-
tients were following. In the studies I-III, all patients were mea-
sured with medication on (MED on). The MED on -state was stud-
ied mainly due to the risk of inconvenient symptoms and the risk
of falling. In addition, it has been observed before that medication
cannot restore the temporal EMG pattern into normal [151]. That is,
medication can decrease differences in the EMG patterns between
PD patients and healthy controls but not remove them completely.
In the study II, 13 patients were measured also with medication
off (MED off, no medication 24 hours before the measurement). In
the study IV, all patients with DBS were off-medication during the
measurements.
The number of measurements per each subject in the studies
I-IV was following. EMG and kinematic measurements were per-
formed once for the healthy controls in all studies I-IV and for the
patients in the studies I and III. In the study II, the measurements
were performed twice for 13 patients (with MED on and with MED
off) and once for other patients (with MED on). In the study IV, the
measurements were performed twice for the patients: with DBS
on (stimulator was turned on) and with DBS off (stimulator was
turned off).
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5.1.2 Study protocols
The measurement protocol was chosen as simple and repeatable be-
cause the measurements were performed in several countries and it
was important to get comparable and reliable results. Both the iso-
metric and dynamic contractions were chosen for analysis because
they could provide different kind of information about the recruit-
ment of motor units and they could be sensitive to different types
motor symptoms.
During the isometric task, the subjects were asked to hold their
elbows at a 90° angle with their palms up. The movement of the
arm was not restricted. The isometric contraction lasted for 10–30
seconds and the measurement was performed during several load-
ing conditions. However, only the unloaded condition was ana-
lyzed in the studies I and II, because the PD-related EMG bursts are
most visible in the signals of unloaded condition [116]. In addition,
the parkinsonian tremor is often reduced when the muscle becomes
loaded. The effects of loading on the EMG and acceleration signal
characteristics were studied in a closely related study [116].
During the dynamic task, the subjects were asked to flex and
extend their both elbows vertically and freely in two-second cycles
with their palms up. The forearms were moved with full ROM,
and one second was used for flexion and one second for exten-
sion. However, because of bradykinesia, all patients could not fol-
low this rate of movement, which may have affected the measured
EMG and acceleration signals. At least four flexion–extension cy-
cles were recorded for each subject in the study III and at least eight
in the study IV. Although the measurements were performed dur-
ing different loading conditions, only the unloaded condition was
analyzed in the studies III and IV.
5.1.3 Measurement technique
During the isometric and dynamic tasks in the studies I-IV, sur-
face EMGs were registered continuously from the biceps brachii
(BB) muscles and the accelerations of forearms simultaneously from
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the wrists (see Fig. 5.1). In addition, the inclinations of fore-
arms were measured from the wrists in the studies I-III. Surface
EMG and acceleration measurements were chosen for characteriz-
ing PD because they are simple, easily available, cost-effective and
non-invasive methods for quantifying the neuromuscular function
and movement. It was supposed that surface EMG could provide
more direct information about PD than the kinematic measure-
ments based on movement. All measurements were performed by
using the ME6000 -biosignal monitor (Mega Electronics Ltd., Kuo-
pio, Finland) and the same type of sensors. All signals were sam-
pled with the rate of 1000 Hz.
Figure 5.1: EMG electrodes over the BB muscle (left), and the accelerometer and incli-
nometer on the wrist (right).
Disposable Ag/AgCl electrodes (Medicotest, model M-00-S,
Ølstykke, Denmark) were used for EMG registration in bipolar con-
nection. They were attached on the skin surface over the BB mus-
cles with an inter-electrode spacing (center to center) of 3 cm. The
ground electrodes were placed 6–7 cm laterally from the recording
electrodes. Raw EMG signals were analogically band-pass filtered
with an anti-aliasing filter (Butterworth, band-pass 1− 500 Hz), am-
plified (differential amplifier, common-mode rejection ratio > 130
dB, total gain 1000, noise < 1 µV) and A/D converted (14-bit).
The accelerations of forearms were registered by using tri-axial
accelerometers (Mega Electronics Ltd., range ±10 g, 14-bit A/D
converter) and the inclinations of forearms by using bi-axial in-
clinometers (Mega Electronics Ltd., range ±90°, 14-bit A/D con-
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verter), which were attached to palmar sides of subject’s wrists with
wrist supports. All signals were stored in a computer for later anal-
ysis. The inclinometer data were used in the studies I-III only for
finding the beginning and ending time instants of the isometric con-
traction and for separating the flexion and extension phases of the
movement. The EMG and acceleration data were used for a more
detailed analysis.
5.2 ANALYSIS OF EMG AND ACCELERATION SIGNALS
This chapter describes the methods that were used for analyzing
the measured EMG and acceleration signals in the studies I-IV. In
all studies I-IV, several PD related features were extracted from the
signals of patients and healthy controls, and a principal component
-based approach was used for the discrimination of subjects. All
computations and signal processing were performed by using the
MATLAB software and programming language (The MathWorks,
Inc.).
Before analysis, the measured signals were pre-processed thor-
oughly. Low-frequency trends were removed from EMG and accel-
eration signals by using the smoothness priors method [170] in all
studies I-IV. The high-pass cut-off frequencies were 10 Hz for EMG
and 2 Hz for acceleration. Low-pass filtering (ninth order Butter-
worth low-pass filter with 110 Hz cutoff) was used for removing the
DBS artifact from the EMG signals in the study IV. In that study, the
low-pass filtering was performed similarly for all subjects (patients
and controls). The resultant of the acceleration was calculated from
the three components of acceleration signal and used for analysis
in all studies I-IV.
5.2.1 EMG and acceleration signal features
During the analysis of measurements, a large number of features
were extracted from the surface EMG and acceleration signals. Only
the best parameters for characterizing PD were chosen into the ap-
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proaches that are presented in the studies I-IV. The used signal fea-
tures and their notations in the studies I-IV are listed in Table 5.2.
The subscripts r and l in the notations stand for the side of the
body. The parameters were calculated as epoch averages from the
isometric EMG and acceleration signals and as time-varying from
the dynamic signals.
Table 5.2: Extracted signal features in each study I-IV.
Study Signal features Notations
I sample histogram of EMG -
crossing rate expansion of EMG -
II sample kurtosis of EMG kr and kl
crossing rate variable of EMG CRr and CRl
correlation dimension of EMG D2,r and D2,l
recurrence rate of EMG %RECr and %RECl
sample entropy of ACC SampEnr and SampEnl
coherence between EMG and ACC Cohr and Cohl
III recurrence rate of EMG %RECr and %RECl
cross-recurrence rate of EMG %RECr,l
wavelet variable of EMG Wmax,r and Wmax,l
cross-wavelet variable of EMG Wmax,rl
power of ACC Pacc,r and Pacc,l
sample entropy of ACC SampEnr and SampEnl
IV correlation dimension of EMG D2,r and D2,l
recurrence rate of EMG %RECr and %RECl
root mean square amplitude of ACC RMSr and RMSl
sample entropy of ACC SampEnr and SampEnl
coherence between EMG and ACC Cohr and Cohl
Features of EMG signal morphology
Because the EMG signal is a sum of MU action potentials, its pattern
is a spiky impulse-like waveform. The information about PD is in
the morphology of an impulse-chain. The EMGmorphology cannot
be effectively analyzed by using only conventional amplitude- and
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Fourier-based methods. Study I aimed to quantify EMG signal mor-
phology in PD compared to healthy subjects by extracting statistical
information from the signals with sample histograms and crossing
rate expansions. Sample histograms have been previously used for
studying EMG probability densities in [24] and the crossing rates
have been proposed for quantifying muscle fatigue in [74, 86].
In the study I, the sample histograms were calculated from the
scaled (between -1 and 1) EMG signals with 200 bins. The cross-
ing rate expansions were calculated from the scaled EMGs as the
number of crossings at given threshold levels. A crossing means
here an event when two neighboring values in a time series are on
opposite sides of the threshold level. The formation of crossing rate
expansion with 11 threshold levels is illustrated in Fig. 5.2. In the
study I, the number of different threshold levels was 201.
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Figure 5.2: Formation of crossing rate expansion with 11 threshold levels (plotted as lines
in relation to the EMG signal).
In the study II, two parameters (k and CR) were calculated for
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measuring the spikiness of EMG signals. Sample kurtosis was cal-
culated as the fourth centered moment of the time series x:
k =
E{(x− µx)4}
σ4x
, (5.1)
where E{·} means the expected value, and µx is the mean and σx
the standard deviation (SD) of the sample values. The kurtosis has
been used for analyzing EMG signals during the past few years
in [1, 76, 116, 128, 180, 192].
The CR variable was calculated as the width/height of the cross-
ing rate expansion. The width of the crossing rate expansion was
defined at the level of 50 crossings/second and the height as the
maximum value of the crossing rate expansion.
Spectral-based features
In spectral analysis, the aim is to present the signal in the frequency-
domain by estimating its power spectral density. The PSD estima-
tion can be based on a Fourier transform or wavelet transform or
on parametric modeling of the signal. In this thesis, the Fourier-
and wavelet-based approaches were used for analysis. The discrete
Fourier transform of a discrete signal x is of the form
X( fk) =
Nx−1
∑
n=0
xne
−i2pink/Nx , (5.2)
where xn is the signal value at time index n, Nx is the length of the
signal and k is the index of the frequency fk. There are different
PSD estimators available. In this thesis, periodograms were used
for analysis. The periodogram PSD estimate of the signal xn is
Px( fk) =
1
Nx fs
∣∣∣∣∣
Nx−1
∑
n=0
xne
−i2pink/Nx
∣∣∣∣∣
2
, (5.3)
where fs is the sampling frequency of the signal x. The vari-
ance of the periodogram estimate can be reduced by averaging the
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periodograms over short signal epochs. Windowing (i.e. multi-
plying the signal with a window function) is often used for de-
creasing the spectral leakage (broadening of spectral peaks). In
Welch’s periodogram approach [184], a discrete window function
w = (w0, . . . ,wNe−1) is applied to each signal epoch x(j) of length
Ne and the epochs are allowed to overlap. The Welch’s averaged
periodogram is obtained as
Px( fk) =
1
Me
Me
∑
j=1

 1
Ne fsU
∣∣∣∣∣
Ne−1
∑
n=0
wnx
(j)
n e
−i2pink/Ne
∣∣∣∣∣
2

 , (5.4)
where Me is the number of overlapping epochs and
U =
1
Ne
Ne−1
∑
n=0
w2n (5.5)
is the window energy.
The cross-spectral density Pxy( f ) between signals x and y can
be estimated from the Fourier transform of the cross-correlation
function
rxy(τ) =
E{(xn − µx)(yn+τ − µy)}
σxσy
, (5.6)
where τ is the time lag, and µx and µy are the mean and σx and
σy the SD values of x and y. The similarity of two signals in the
frequency domain can be quantified by calculating the coherence
from the PSDs of the signals (Px( f ) and Py( f )) and from the cross-
spectral density Pxy( f ). The magnitude-squared coherence is de-
fined as
Cxy( f ) =
|Pxy( f )|2
Px( f )Py( f )
(5.7)
and it gives values between 0 and 1.
In the studies II and IV, the magnitude-squared coherence
(5.7) was estimated between EMG and acceleration signals by us-
ing the Welch’s averaged periodogram method (5.4) for estimat-
ing the PSDs and the cross-spectral density. The method has
been used for the analysis of hand and finger movements also
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in [35, 70, 84, 168, 176]. Variable Coh was calculated in the stud-
ies II and IV as the area of the coherence spectrum in the frequency
range 0–50 Hz.
While in Fourier approach the basis functions in the spectral
decomposition (5.2) are global functions, in wavelet approach [3]
the functions are local. Therefore, the wavelet-based methods can
be more effective than the Fourier-based methods in detecting time
evolutions in frequency distributions [30]. The basic idea in the
wavelet transform is to decompose the signal into a set of basis
functions, which are obtained by scaling and shifting the wavelet
function ψ(t). Different kinds of wavelet functions have been de-
fined for analysis. In continuous form, the wavelet transform of the
signal x(t) is defined as
Wx(a, b) =
1√
a
∫ ∞
−∞
x(t)ψ∗(
t− b
a
)dt, (5.8)
where a is the scale, b is the shift, and (·)∗ denotes the complex con-
jugate operator. For discrete signals one must use discrete wavelet
functions for analysis. The squared magnitude of the wavelet trans-
form is called the scalogram
PWx (a, b) = |Wx(a, b)W∗x (a, b)|. (5.9)
If the wavelet transforms of two signals x and y are denoted with
Wx(a, b) and Wy(a, b), the wavelet cross-scalogram is defined as
PWxy(a, b) = |Wx(a, b)W∗y (a, b)|. (5.10)
In the study III, the discrete EMG signals were analyzed by us-
ing discrete wavelet functions. The Morlet wavelet was used as the
wavelet function as in [30, 93, 161]. The scalograms (5.9) were cal-
culated from the EMG signals of both sides of the body and the
cross-scalogram (5.10) between the right and left side signals. The
obtained scalograms and cross-scalograms were scaled to present
the percentage of energy for each wavelet coefficient as a function
of time. The wavelet parameter Wmax was calculated as the max-
imum energy of all wavelet coefficients from both the scalograms
and the cross-scalograms as a function of time.
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Parameters of nonlinear dynamics
Several parameters of nonlinear dynamics were used for analyzing
EMG and acceleration signals in the studies II-IV. These parameters
were: the correlation dimension of EMG, the recurrence and cross-
recurrence rate of EMG, and the sample entropy of acceleration.
EMG signals of PD patients have been analyzed by using methods
of nonlinear dynamics in the closely related studies [116, 148] and
in [53], and the acceleration signals in [162, 163, 176].
In the nonlinear dynamics, an original time series x is used to
form embedding vectors ui
ui = [xi xi+λ xi+2λ . . . xi+(m−1)λ], (5.11)
where λ is the delay parameter and m the embedding dimension
[169]. The number of different embedding vectors is
Nm = Ne − (m− 1)λ, (5.12)
where Ne is the epoch length of the time series x.
The correlation dimension [71] was calculated in the studies II
and IV for quantifying the complexity of EMG signals. It can be
calculated as follows. First, the Euclidean distances between each
pair of embedding vectors ui and uj in (5.11) are quantified as
de(ui, uj) =
√√√√m−1∑
k=0
|xi+kλ − xj+kλ|2. (5.13)
The correlation sum is then calculated as
Cm(r) =
1
N2m
Nm
∑
i,j=1
Θ(r− de(ui, uj)) (5.14)
Θ(s) =
{
0, s < 0
1, s ≥ 0,
where r is the threshold distance. The correlation dimension is
formally defined as
D2(m) = lim
r→0
lim
Nm→∞
logCm(r)
log r
. (5.15)
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Practically, D2 is calculated as the slope of the regression curve (lin-
ear part of the curve) in the logarithmic representation. The param-
eter has been used for analyzing EMG signals in [7,54,106,116,166].
The recurrence rate [41, 183] was calculated in the studies II-IV
for quantifying recurring patterns in the EMG signals. It can be
calculated from the embedding vector distances (5.13) as a percent-
age of distances that are below of a threshold value. The cross-
recurrence rate was calculated in the study III between the right
and left side EMG signals. In the calculation of cross-recurrence
rate, the embedding vectors (5.11) are formed for both time series
and the Euclidean distances (5.13) are evaluated between the em-
bedding vectors of the two different time series. The recurrence
quantification analysis has been used for analyzing EMG signals
in [33, 34, 36, 49, 56, 60, 85, 108, 116, 182].
The sample entropy [147] was calculated in the studies II-IV
for quantifying the complexity of acceleration signals. It can be
calculated as follows. First, the distance between the embedding
vectors ui and uj in (5.11) is defined as the maximum difference of
their corresponding scalar components
dmax(ui, uj) = max{|xi+kλ − xj+kλ|, 0 ≤ k ≤ m− 1}. (5.16)
Then a sum Φm(r) is formed as
Φm(r) =
1
N2m
Nm
∑
i,j=1,i 6=j
Θ(r− dmax(ui, uj)) (5.17)
where Θ(·) is as in (5.14). Finally, the sample entropy is calculated
as
SampEn(m, r,Ne) = − ln Φ
m+1(r)
Φm(r)
. (5.18)
The parameter has been used for analyzing acceleration signals in
[104].
Amplitude and power of acceleration
In the study IV, the root mean square amplitude (2.2) was calculated
from the isometric acceleration recordings for quantifying tremor.
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In the study III, variable Pacc was extracted from the dynamic accel-
eration signals y as the signal energy per second
Pacc =
∑
Ne
i=1 y
2
i
Ne/ fs
, (5.19)
where fs was the sampling frequency and Ne the length of the signal
epoch.
5.2.2 Discrimination between subjects
When discriminating between subjects or between different states
of the subjects (such as between DBS on- and DBS off-states) on
the basis of biosignal measurements, there are often many parame-
ters that can capture essential information in the measured signals.
Each of the parameters describes one feature in the signals such
as the amplitude or the complexity. By using a dimension reduc-
tion technique, such as the principal component approach [90], it is
possible to reduce the number of features while keeping as much
information about the original signal parameters as possible. Prin-
cipal components have been used for the analysis of EMG signal
characteristics for example in [105, 139, 158]. Another name for the
PC approach is the Karhunen-Loe´ve transform [172].
Principal components
All of the studies I-IV were based on a novel or innovative way of
combining a PC approach with the selection of feature vectors. The
PC approach was used for reducing the number of signal features
and for transforming the original possibly correlated parameters
into uncorrelated parameters.
In the PC approach, the original signal features pj (j =
1, 2, ...,Np) are used to form feature vectors zj ∈ RNp
zj = [p1 p2 . . . pNp ]
T, (5.20)
where (·)T denotes the transpose. The original signal features in
(5.20) can be vectors (study I) or scalars (studies II-IV). In the case
Dissertations in Forestry and Natural Sciences No 62 49
Feature Extraction Methods for EMG and Kinematic Measurements in PD
of vectors, each vector component is thought to be one signal pa-
rameter pj. When two or more vectors are concatenated to form the
feature vector zj, such as in the study I, the method is called the
augmented PC approach.
In the study I, three feature vectors were formed for each sub-
ject: one containing the EMG sample histogram, one containing
the crossing rate expansion and one containing both of them (aug-
mented PC approach). The PC approach was applied separately for
the histograms, for the crossing rate expansions and for the com-
binations of them. The feature vectors of three PD patients and
three healthy controls in the case of augmented PC approach are
illustrated in Fig. 5.3.
In the study II, one feature vector was formed for each control,
for each patient with MED on and for 13 patients with MED off by
using the twelve EMG and acceleration parameters that are detailed
in Table 5.2. The signal variables were normalized (to zero mean
and unit SD of all subjects) before applying the PC approach. The
PC approach was applied once.
In the study III, two feature vectors both containing ten signal
variables (see Table 5.2) were formed for each subject: one feature
vector containing the normalized flexion variables and one feature
vector containing the normalized extension variables. The normal-
ization of variables was performed with respect to all subjects. Al-
though the signal parameters were originally calculated as time-
varying, only the mean values of the parameters during flexion
and extension were used in the feature vectors. The PC approach
was applied separately for the flexion and extension phases of the
movement.
In the study IV, one feature vector was formed for each healthy
control and two feature vectors (one with DBS on and one with
DBS off) for each patient by using ten normalized (to zero mean
and unit SD of controls) signal variables (see Table 5.2). The PC
approach was applied once.
The basic idea in the PC approach [90] is to model the feature
vector zj as a weighted sum of basis vectors φk (k = 1, 2, ...,K). This
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Figure 5.3: The feature vectors of three patients (black) and three controls (gray) in the
study I. Each feature vector consists of a concatenated crossing rate expansion and his-
togram. Three eigenvectors corresponding to the three largest eigenvalues.
can be done in the matrix form as follows. For M measurements,
the feature matrix Z ∈ RNp×M is formed by placing the feature
vectors z1, ..., zM in its columns.
Z = [z1 z2 . . . zM] (5.21)
The feature matrix Z is then modeled with a linear model
Z = Hθ + v, (5.22)
where H = [φ1 φ2 . . . φK] ∈ RNp×K is the model matrix and matrix
θ = [θ1 θ2 . . . θM] ∈ RK×M contains the model weights. Matrix
v = [v1 v2 . . . vM] ∈ RNp×M contains the model errors. In studies
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I-IV, the basis vectors φk were selected to be eigenvectors of the data
correlation matrix
RZ =
1
M
ZZT. (5.23)
That is, for each eigenvector RZφk = αkφk was true [2], where αk
is the eigenvalue that corresponds to the eigenvector φk. Since the
eigenvectors are orthonormal, the least squares solution [83] for the
model weights θ is of the form
θˆ = (HTH)−1HTZ = HTZ. (5.24)
These weights are called the principal components. By choosing
K (K < Np) eigenvectors corresponding to K largest eigenvalues
for modeling, the best K-dimensional orthogonal approximation for
the data set is obtained. The PCs are the new uncorrelated features
and they can be used for discriminating between subjects in a low-
dimensional eigenspace (feature space).
Cluster analysis and validation of results
Cluster analysis can be used for grouping objects with similar fea-
tures into groups. In EMG analysis, clustering has been used for
example in identifying different hand movements (hand opening,
wrist flexion etc.) on the basis of calculated EMG parameters [98].
In kinematic analysis, clustering has been used for example in
grouping gait patterns of stroke patients on the basis of spatiotem-
poral and kinematic gait characteristics [124].
Several algorithms are available for clustering. In the studies
II and III, an iterative k-means algorithm (see details in [172]) was
used for clustering the feature vectors of healthy controls and PD
patients into groups in a two-dimensional eigenspace. With cluster
analysis it was possible to test, if the PD patients can be differenti-
ated from the healthy controls on the basis of EMG and acceleration
signal features. The used k-means algorithm is described briefly.
The vectors to be clustered are denoted here with zj and the only
parameter given to the algorithm is S, which is the number of clus-
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ters. The algorithm begins by choosing initial estimates for S cluster
center points. In each iteration step:
1. It is determined to which cluster all vectors zj belong. The vec-
tor zj belongs to that cluster for which the squared Euclidean
distance between the vector and the cluster center point in the
low-dimensional eigenspace is minimized.
2. The cluster center points are updated to be the mean of the
vectors zj in each cluster in the low-dimensional eigenspace.
The iteration continues until the sum of vector-to-center point dis-
tances summed over all S clusters is minimized. In the studies II
and III, a two-phase iterative algorithm was used. The first phase
of it was as explained above. In the second phase of the algorithm,
vectors zj were reassigned individually if doing so decreased the
sum of distances. The cluster center points were updated after each
reassignment.
The validation of the clustering results in the studies II and III
was performed by using a modified leave-one-out method (the ba-
sic version of the method is described in [172]). In the modified
approach, the eigenvectors and PCs are computed for each combi-
nation of M− 1 feature vectors, where M means the total number
of feature vectors. That is, one feature vector is left out of the group
each time the eigenvectors and PCs are computed. The clustering
is then performed for each combination of M − 1 feature vectors,
and in each case, it is tested to which cluster the feature vector that
was left out belongs. In the studies II and III, the correct ratings of
clustering were defined as the percentage of controls that belong to
the control cluster and the percentage of patients that belong to the
patient clusters.
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6 Results
The main results of the studies I-IV are presented in this chapter
and divided into five sections. The first section presents the most
significant findings from the visual examination of measured sig-
nals. The second section presents the calculated EMG and accel-
eration signal features. The third section describes, what can be
interpreted from the solved eigenvectors and PCs. The fourth sec-
tion presents the results of the discrimination analysis and the fifth
section the results of the quantification of treatment effects.
6.1 VISUAL EXAMINATION OF SIGNALS
The isometric EMG and acceleration recording were visually exam-
ined in the studies I and II. Typical EMG and acceleration signals of
one healthy control and one PD patient are presented in Fig. 6.1. It
is observed that the right side EMG signal of the PD patient differs
from the EMG signals of the healthy control by containing recur-
ring spiky structures. The recurring structures are likely due to the
increased level of MU synchronization [53].
The right side acceleration signal of the patient in Fig. 6.1 differs
from the acceleration signals of the healthy person by containing
regular high-amplitude oscillation. This oscillation is likely due to
the resting and postural tremor. The patient in Fig. 6.1 is clearly
more affected by the disease in the right side of the body.
The dynamic EMG and acceleration signals were visually exam-
ined in the study III. Typical recordings of one PD patient and one
healthy control during two elbow flexion-extension cycles are pre-
sented in Fig. 6.2. It is observed that the EMG signals of the PD
patient are characterized by recurring EMG bursts and the accel-
eration recordings by containing regular high-amplitude oscillation
during the extension phases of the movement. The oscillation in the
acceleration signal (which was high-pass-filtered with 2 Hz as cut-
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Figure 6.1: EMG and acceleration recordings of one PD patient (left) and one healthy
control (right) during isometric contraction of BB muscles.
off frequency) is likely due to muscle rigidity and kinetic tremor
(tremor that occurs during movement) in PD. During the flexion
phases of the movement, the differences between the patient and
the control are not as pronounced.
The EMG and acceleration recordings of PD patients with DBS
were visually examined in the study IV. Typical signals of one PD
patient with DBS on and off during the isometric task are presented
in Fig. 6.3. It is observed that the EMG signals of the patient differ
between the DBS on- and DBS off-states by containing more recur-
ring EMG bursts with DBS off than with DBS on. The acceleration
signals of the patient differ between the DBS on- and DBS off-states
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Figure 6.2: EMG and acceleration recordings of one PD patient (left) and one healthy
control (right) during two elbow flexion-extension cycles.
by containing more regular oscillation with DBS off than with DBS
on. The EMG and acceleration signals seem to be more similar with
the signals of the healthy controls (see example in Fig. 6.1) with
DBS on than with DBS off. Visual examination of the dynamic sig-
nals in the study IV revealed that there are differences in the EMG
signal morphology and acceleration signal regularity between the
DBS on- and DBS off-states for a subgroup of patients (patients that
have bigger problems in performing hand movement tasks) but not
for all patients.
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Figure 6.3: EMG and acceleration recordings of one PD patient with DBS off (left) and
with DBS on (right) during the isometric contraction of BB muscles.
6.2 EMG AND ACCELERATION SIGNAL FEATURES
In the study I, the EMG sample histograms and crossing rate expan-
sions were calculated for 25 PD patients and 22 healthy controls. A
typical sample histogram and crossing rate expansion of one PD
patient and one healthy control are presented in Fig. 6.4. It is ob-
served that the sample histogram of the patient is sharper than the
histogram of the healthy control. The crossing rate expansion of the
patient is narrower than the crossing rate expansions of the healthy
person.
In the study II, twelve features were extracted from the isomet-
ric EMG and acceleration signals of 59 healthy controls and 42 PD
patients. The normalized signal features (mean±SD values) for the
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Figure 6.4: EMG signals and the corresponding sample histograms and crossing rate
expansions of one healthy control (left) and one PD patient (right) in the study I.
healthy control group and for the PD patient group are presented
in Fig. 6.5. The results show that parameters SampEn, CR and D2
tend to be lower and parameters k, Coh and %REC higher for the
patients than for the healthy controls. This means that the EMGs
of the patients tend to be less complex and contain more recurring
spiky patterns than the EMGs of the healthy controls. The accel-
eration signals of the patients tend to be more regular and more
coherent with the EMGs than the acceleration signals of the healthy
controls. These observations support the visual findings from the
signals.
In the study III, ten features were extracted from the EMG and
acceleration signals of 59 healthy controls and 49 PD patients. Al-
though the features were calculated as time-varying, only the mean
values of the features for flexion and extension were used for form-
ing the feature vectors. The normalized signal features (mean±SD
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Figure 6.5: Mean ± SD values of normalized signal features for the patient group (◦) and
for the control group (+) in the study II.
values) for the healthy control group and for the PD patient group
in flexion and in extension are presented in Fig. 6.6. The results
show that parameters %REC and Pacc tend to be higher and param-
eters SampEn and Wmax lower for patients than for healthy con-
trols both in flexion and in extension. This suggests following. The
EMGs of the patients tend to contain more recurring patterns than
the EMGs of the healthy controls. The EMG wavelet power tends to
be more spread for patients. The acceleration signals of the patients
tend to be of higher amplitude and more regular than the accelera-
tion signals of the healthy controls. These observations support the
visual findings from the signals.
In the study IV, ten features were calculated from the isometric
EMG and acceleration signals of 13 PD patients with DBS on and
off, and from the signals of 13 healthy controls. The group mean
values of the parameters D2 and SampEn increased and the group
mean values of the parameters %REC, RMS and Coh decreased
with DBS for the patient group. However, the SDs of the variables
were high due to a very heteregeneous patient group. Therefore,
the patient measurements were studied individually.
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Figure 6.6: Mean ± SD values of normalized signal features for the patient group (◦) and
for the control group (+) in the study III.
6.3 INTERPRETATION OF THE FEATURE VECTORS, EIGEN-
VECTORS AND PRINCIPAL COMPONENTS
In the studies I-IV, several signal features (detailed in Table 5.2)
were used to form feature vectors for subjects. PCs were used for
modeling each feature vector as a weighted sum of the eigenvectors.
By visually examining the solved eigenvectors in each study, one
could interpret the PCs (i.e. the weights of the eigenvectors).
In study I (augmented PC approach), three eigenvectors corre-
sponding to the three largest eigenvalues are presented in Fig. 5.3.
The first eigenvector is the best mean-square fit for the feature vec-
tors of all subjects. Thus, it is similar to the mean of all feature
vectors. Therefore, the fist PC describes the amplitude of the his-
togram and the crossing rate expansion with respect to the mean
amplitude of all subjects. The second eigenvector in Fig. 5.3 de-
scribes variations in the peaks (modes) of the histograms and cross-
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ing rate expansions of all subjects. And the third eigenvector in Fig.
5.3 models variations in the heights and widths of the histograms
and crossing rate expansions in the whole data set. It was observed
that the biggest differences between patients and healthy controls
are in the third PC (in the widths and the heights of the histograms
and crossing rate expansions) and some differences are observed in
the first PC. There are no significant differences between the subject
groups in the second PC. Therefore, the discrimination of subjects
was performed with respect to the third and the first PC.
In the studies II-IV, the best PCs for discriminating between PD
patients and healthy controls or between DBS on- and DBS off -
states were chosen for discrimination analysis. By visually exam-
ining the corresponding eigenvectors, one could observe what each
PC describes. For example in the study II, the biggest differences
between patients and controls are in the amplitudes of the original
signal parameters and in the differences between right and left side
parameters.
6.4 DISCRIMINATION RESULTS
The discrimination analysis of the feature vectors in the studies I-III
was performed in a low dimensional eigenspace by analyzing the
calculated PCs. In the study I, a linear discriminant was used for
discriminating between subjects in a two-dimensional eigenspace
(the third PC θj(3) with respect to the first PC θj(1)). The best
discrimination results were obtained by using the augmented PC
approach, in which both the sample histograms and crossing rate
expansions were used for forming the feature vectors. The results
of the augmented PC approach are presented in Fig. 6.7. According
to results, 72 % of the PD patients are discriminated from 86 % of
the healthy controls on the basis of EMG signal morphology.
In the study II, the cluster analysis of subjects was performed in
a two-dimensional eigenspace (PC sum θj(2) + θj(5) with respect to
the first PC θj(1)) by using the k-means algorithm. This PC sumwas
used, because it works better in discrimination than the single PCs.
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Figure 6.7: The third PCs θj(3) with respect to the first PCs θj(1) of 22 healthy controls
(+) and 25 PD patients (◦) in the study I.
The results in Fig. 6.8 show that 90 % of the healthy controls belong
to the cluster O1 and 76 % of the patients in two other clusters O2
and O3. The UPDRS -motor score of the patients (mean ± SD) is
13± 9 in O1, 26± 12 in O2 and 40± 11 in O3. Seven patients with
severe motor symptoms are distinguished in O3. The ten patients
in O1 have only little or no tremor at all in their hands. Five out of
six healthy controls in O2 are younger controls (age < 45 years) and
only one is older. The validation by using the leave-one-out method
(see section 5.2.2) resulted in correct discrimination rates of 90 ± 1
% for the healthy controls and 74 ± 6 % for the patients.
In the study III, the PC approach was applied separately for
the feature vectors in flexion and in extension. The cluster analysis
of subjects was performed in a two-dimensional eigenspace (θj(2)
with respect to θj(1)) by using the k-means algorithm. The results
are presented in Fig. 6.9. According to results, the method can
discriminate 80 ± 1 % of the patient extension movements from
87 ± 1 % of the control extension movements, and 73 ± 1 % of
the patient flexion movements from 82 ± 1 % of the control flexion
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Figure 6.8: PC sum θj(2) + θj(5) with respect to the first PC θj(1) of 42 PD patients (◦)
and 59 healthy controls (+) in the study II. Subjects were clustered into three clusters O1,
O2 and O3 by using the k-means clustering algorithm.
movements. The leave-one-out method (see section 5.2.2) was used
for validation. Typical for the incorrectly clustered patients is that
their UPDRS-motor scores in all areas (rigidity, bradykinesia and
tremor) are low. Most of the incorrectly clustered healthy controls
are older controls.
6.5 QUANTIFYING THE EFFECTS OF TREATMENT
In the study II, the effects of anti-parkinsonian medication on the
feature vectors were examined by using the EMG and acceleration
data from 13 PD patients with MED on and off. The results are
presented in Fig. 6.10. It is observed that in the previously solved
eigenspace (presented in Fig. 6.8), 10 out of 13 patients are closer
to the center point of the control cluster O1 with MED on than with
MED off. Two patients are nearly in the same position with MED on
and off and one patient is clearly further from the healthy controls
with MED on than with MED off.
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Figure 6.9: The second PCs θj(2) with respect to the first PCs θj(1) for 49 PD patients
(◦) and 59 healthy controls (+) in flexion (top) and in extension (bottom) in the study III.
Subjects were clustered into two clusters by using the k-means clustering algorithm.
In the study IV, the effects of DBS were quantified by using the
EMG and acceleration data from 13 PD patients with DBS on and
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Figure 6.10: The PC sum θj(2)+θj(5) with respect to the first PC θj(1) of 13 PD patients
with MED on (◦) and off (△). The MED on- and off-states of each patient are connected
with a line. The three clusters O1, O2 and O3 that were solved in the study II.
off, and 13 healthy age-matched controls. The results are presented
in Fig. 6.11. It is observed that in the two-dimensional eigenspace,
which was generated by using the feature vectors of healthy sub-
jects, 12 out of 13 patients are closer to the center point of healthy
controls with DBS on than with DBS off. The DBS-induced changes
in the distance from the center of healthy subjects and in the clini-
cal UPDRS -motor score are highly individual (see Table 6.1). It is
observed that the method is most sensitive to PD with associated
tremor. The correlation between the clinical rest tremor score (see
Table 6.1) and the distance from the center of healthy controls is
significant (Spearman correlation, p<0.05). The one patient who is
farther from the healthy controls in the feature space with DBS on
than with DBS off has tremor (acceleration signal) with higher am-
plitude and regularity with DBS on than with DBS off. In addition,
the EMG recordings of the patient are more complex (lower %REC
and higher D2) with DBS off than with DBS on. For that patient,
the measurement results contradict the subjective clinical scores.
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Figure 6.11: The third PCs θj(3) with respect to the first PCs θj(1) of 13 healthy controls
(+) and 13 PD patients with DBS on (◦) and off (△). The patients were divided into two
figures, but the controls are the same in both figures. (a) Patients 4, 5 and controls. (b) The
remaining patients and controls. The DBS on- and off-states of each patient are connected
with a line.
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Table 6.1: Total UPDRS -motor scores, resting tremor scores and the distances (Dist) from
the center of healthy controls with DBS on and off.
Patient
no.
UPDRS
off
UPDRS
on
Tremor
right
off
Tremor
right
on
Tremor
left
off
Tremor
left
on
Dist off Dist on
1 56 43 2 2 2 1 26 25
2 64 48 2 1 3 2 32 12
3 59 40 2 1 2 2 7 5
4 34 14 1 0 3 2 180 30
5 71 42 4 1 3 0 289 4
6 38 31 2 1 1 0 5 12
7 47 28 1 0 1 0 6 2
8 57 33 2 0 1 0 6 4
9 43 34 1 1 1 1 13 11
10 43 24 1 0 0 0 11 10
11 44 30 0 0 0 0 6 5
12 62 38 1 0 2 0 5 4
13 43 30 0 0 0 0 5 3
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7 Discussion and conclusions
In Parkinson’s disease, the dopaminergic neuronal loss in the basal
ganglia of the cerebra affects the motor cortical activity during mus-
cle contractions, which leads to abnormalities observed in skeletal
muscles [155]. The skeletal muscle function can be quantified by
using EMG and kinematic measurements. In this thesis it was hy-
pothesized, if the EMG and kinematic signal features are sensitive
to PD and to the effects of PD treatment. The aim was to develop
methods of surface EMG and kinematic analysis for discriminating
between PD patients and healthy persons, for quantifying the mo-
tor impairment in PD, and for quantifying the effects of treatment.
7.1 MOST SIGNIFICANT RESULTS
In this thesis, PD characteristic features were extracted from EMG
and acceleration signals and three novel approaches were devel-
oped for discrimination between PD patients and healthy persons
on the basis of the extracted signal features. One approach was
based on analyzing the surface EMG signal morphology (study I).
One approach was based on analyzing isometric (study II) and one
approach on analyzing dynamic (study III) recordings. Principal
components were used in each study for discrimination between
subjects. In the study IV, a PC-based tracking method was pre-
sented for quantifying the effects of DBS treatment on the basis of
EMG and acceleration measurements and analysis. The method
development was supported by gathering EMG and acceleration
measurement data from 72 healthy controls and 62 PD patients that
were in different stages of the disease and in different states of the
treatment during the measurements. The number of patients in the
studies II and III was higher than in most of the other studies that
have analyzed EMG signal characteristics in PD.
The three approaches, that were developed in the studies I-III,
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could reasonably well discriminate between the measured PD pa-
tients and healthy controls. The correct discrimination rates were
72 % for patients and 86 % for controls on the basis of surface EMG
signal morphology, 76 % for patients and 90 % for controls on the
basis of isometric EMG and acceleration recordings, 73 % for pa-
tients and 82 % for controls on the basis of elbow flexion move-
ments, and 80 % for patients and 87 % for controls on the basis of
elbow extension movements. These percentages predict the sensi-
tivities and specificities of the methods in the subject groups that
were studied. The results of the study IV show that the measured
EMG and acceleration signals of PD patients with DBS were more
similar with the signals of the healthy controls with DBS on than
with DBS off. The results indicate that the developed approaches
are potentially useful for quantifying objectively the neuromuscular
and motor function, and the effects of treatment in PD.
In this thesis, both the isometric and dynamic muscle contrac-
tions were studied. The best discrimination rates between patients
and healthy controls were obtained by analyzing the isometric EMG
and acceleration recordings and by analyzing the elbow extension
movements. This result is consistent with a previous study [150],
in which the elbow extension movements were more impaired than
the flexion movements of PD patients. It was observed in the stud-
ies II-IV that the isometric and dynamic approaches are sensitive to
different kinds of patients. The isometric approach is sensitive to
patients with associated tremor. The dynamic approach is sensitive
to patients with motor symptoms in all areas (rigidity, bradykinesia
and tremor) and especially to patients with problems in performing
movement tasks. This shows that the analysis of both kind of move-
ments is essential when examining PD patients and when aiming
to increase our understanding of the neuromuscular dysfunction in
PD.
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7.2 NOVELTY IN SIGNAL ANALYSIS
During the method development in the studies I-IV, a large number
of features were extracted from the EMG and acceleration signals
of patients and controls. In each study, the most effective features
for characterizing the signals of PD patients or the DBS-induced
changes in the signals were chosen into the feature vectors for dis-
crimination. The chosen EMG features were not conventionally
analyzed parameters (MDF, MNF, RMS and ARV) but they were
based on nonlinear dynamics, signal morphology, wavelets and
EMG-acceleration coherence. Because the EMG signals are impulse-
like waveforms and the information about PD is in the signal mor-
phology (recurring spikes and bursts), the conventional methods
are not as effective as the used methods in analyzing the signals of
PD patients [116]. In addition to this thesis and to the related stud-
ies [116,148], there have been only one [53] or few studies, in which
a method of nonlinear dynamics has been used for studying EMG
in PD. The study IV is the only study that has analyzed the effects
of DBS by using methods of nonlinear dynamics. The novelty of the
analysis methods differentiates this thesis from many other studies
that have analyzed EMG and kinematic characteristics in PD.
All of the studies I-IV were based on a novel or innovative way
of combining the PC approach with the selection of feature vec-
tors instead of analyzing the statistics of single signal parameters.
The PC approach provided a better discrimination between subjects
by capturing the essential information in the combination of vari-
ables. The use of PC approach in combination with a set of signal
features differentiates this thesis from the other studies that have
aimed to characterize EMG and kinematic signals of PD patients.
By using a PC-based approach, it is possible to examine the signals
of subjects in a feature space on individual level. In the study I, the
PC technique revealed that the biggest differences between patients
and healthy persons were in the widths and the heights of the EMG
sample histograms and crossing rate expansions. In the study II, the
PC technique revealed that the biggest differences between patients
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and healthy persons were in the amplitudes of the signal features
and in the side differences between right and left side variables.
The asymmetry of symptoms is, in fact, characteristic for PD [88].
7.3 COMPARISON WITH UPDRS
The clinical UPDRS -motor scores reflect the severity of motor
symptoms of PD. However, these scores are evaluated subjectively
and they can be nonlinear by nature [5]. The correlation between
the UPDRS -motor scores and the calculated PCs was studied
briefly in this thesis. In the studies II and III, a significant corre-
lation (Spearman correlation, p≤ 0.01) was observed between the
calculated PCs and the total UPDRS -motor scores. And in the
study IV, a significant positive correlation (Spearman correlation,
p≤ 0.05) was observed between the clinical rest tremor score and
the distances from the center of healthy controls in the feature
space. It was observed in the studies II and IV, that strong DBS-
or medication-induced changes in the signal features did not al-
ways correspond to strong changes in the UPDRS -motor scores
and vice versa. Because of following reasons, the correlation was
not analyzed more deeply in this thesis. In the studies II and III,
the UPDRS -examination was not performed at the same time with
the measurement for all patients. This was a problem because it
was observed in the measurements that the severity of PD symp-
toms could evolve rapidly. Furthermore, for 11 patients only the
total UPDRS -motor score was known. The total UPDRS -motor
score is a complicated score that consists of sub-scores for different
kinds of motor impairments (tremor, rigidity etc.) in different parts
of the body (arms, legs, head etc.). In this thesis, only upper arm
movements and BB muscles were examined. It is expected that the
results would be similar from other muscles as well.
In the study IV, there was one patient, whose tremor (accelera-
tion signal) was of higher amplitude and more regular with DBS
on than with DBS off. The signal characteristics of the patient
were more similar with the signal characteristics of the healthy
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controls with DBS off than with DBS on. In the clinical UPDRS
-examination, the tremor score of the patient was defined higher
with DBS off than with DBS on. In the case of this patient, the re-
sults from the measurements and from the subjective clinical eval-
uation were contradictory.
7.4 AGING, DISEASE SEVERITY AND MEDICATION
The average age of the onset of PD symptoms is 60 years [72]. It
has been observed previously that aging itself may change the EMG
and acceleration signal characteristics [77, 82]. In the studies I-III
and in the related study [116], both younger and older healthy con-
trols were examined. It was observed that aging affects more the
EMG and acceleration signal features during dynamic than during
isometric contractions. In the study III, the dynamic EMG signals
of some older controls contained recurring EMG bursts and the
acceleration recordings oscillation during the movement. This ob-
servation is consistent with previous studies, in which older adults
demonstrated loss of acceleration complexity [82] and higher lev-
els of EMG burst activity [77] during movement when compared
to younger adults. It is also consistent with the study [116], in
which no significant differences were observed between healthy
young and old controls in the EMG parameters during isometric
muscle contractions of BB. It must be noted that, if unchecked, also
other non-parkinsonian tremors (e.g. strong physiological tremor,
essential tremor or metabolic tremor) may affect the EMG and ac-
celeration signal features.
The patient groups in the studies I-IV were heterogeneous. The
severity of PD ranged from mild to severe (total UPDRS -motor
scores between 2–71) and the patients had various motor symptoms
including tremor, rigidity, bradykinesia and problems with the bal-
ance. The variety of motor symptoms differentiates this thesis from
many other studies that have analyzed EMG signal characteristics
of PD patients. It was observed in the studies II and III that a part of
the mildly impaired patients (UPDRS -motor score < 10) could not
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be discriminated from the healthy persons by analyzing the EMG
and acceleration data. However, there were also patients with mild
PD that were clearly discriminated from the healthy persons. This
indicates that the developed approaches could work at early stages
of PD. However, the sensitivity of the methods in early diagnostics
should be tested with a large group of mildly impaired patients or
with patients before actual diagnosis of the disease.
The patients in the studies I-III were on-medication during
the measurements because of ethical reasons (inconvenient symp-
toms and an increased risk of falling). This may have affected the
EMG and acceleration signal features by reducing differences be-
tween patients and healthy persons. It has been observed, how-
ever, that medication cannot normalize the signal characteristics
[151, 177, 178]. In the study II, a small group (N=13) of patients
were examined with medication on and off. These patients were
selected by a neurologist and they were considered ”safe” as re-
gards falling. It appeared that the signal characteristics of 10 out
of 13 patients were more similar with the signal characteristics of
the healthy controls with MED on than with MED off. This indi-
cates that the used analysis methods were able to detect medication-
induced changes in the neuromuscular function of patients. The
effects of medication on the EMG and acceleration signal features
were highly individual, which may describe different stages of the
disease and different responses to medication. The results are con-
sistent with the closely related study [148], in which the effects of
medication were quantified once an hour before and after taking
the medication. It was observed that the EMG signals changed into
less spiky and the acceleration recordings into more complex after
taking the medication. A reverse phenomenon in the signal char-
acteristics was observed 3–4 hours after taking the medication. On
the basis of the results, larger studies are suggested for evaluating
the clinical value of the used analysis methods in quantifying the
effects of PD medications.
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7.5 SIGNAL NON-STATIONARITY AND FILTERING
The EMG signal amplitude is relatively low and the signal is sen-
sitive to noise that is coming from other electrical sources. It was
observed in this thesis that some of the measured EMG signals were
contaminated with the power line interference. The contaminated
signals were completely excluded from the analysis in the studies
I-III.
It was observed in the studies I and II that sometimes a large
MU was firing constantly in the proximity of the recording elec-
trode leading to recurring impulse-like structures in the EMG sig-
nal. In that case, a better placement of recording electrodes would
be advisable.
One essential thing to remember in the analysis of biosignals
from patients with DBS is the removal of DBS artifact because it
and its filtering may affect the calculated signal parameters. In the
case of EMG, the DBS artifact has often been removed by low-pass
filtering the rectified signal with a very low (20–60 Hz) cut-off fre-
quency [107,162,163,177,178]. Filtering with a very low cut-off fre-
quency may remove PD related information from the EMG signals.
Therefore, several filtering techniques were tested for DBS artifact
filtering prior to the study IV. The aim was to remove the DBS ar-
tifact from the signal as effectively as possible without removing
important information and to perform the filtering in the same way
for all subjects in order to get comparable results. The low-pass
cut-off frequency 110 Hz was the highest value that removed the
stimulation artifact from the signals of all subjects in the study IV.
7.6 CONCLUSIONS
In each study I-III, an objective and quantitative approach was pre-
sented for discrimination between PD patients and healthy persons
on the basis of EMG and acceleration measurements and analysis.
In the approaches, a simple and repeatable measurement protocol
was combined with a novel method of signal analysis and a correct
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discrimination rate of 72-80 % was obtained for patients. This rate
corresponds to the accuracy of the PD diagnosis in the clinicopatho-
logical studies (brain bank material) from the UK and Canada [173].
The results of the studies II and IV show that these simple EMG and
acceleration measurements in combination with novel signal anal-
ysis can detect DBS- or medication-induced improvements in the
neuromuscular and motor function of PD patients.
The results indicate that EMG and acceleration measurements
in combination with the developed analysis approaches are poten-
tially useful for discriminating between PD patients and healthy
persons, and for quantifying objectively the effects of treatment in
PD. It is hoped that the results of this thesis can help in creating
a practical method for quantifying motor impairment in PD and
the effects of treatment on individual PD patients. This practical
method could consist of several potential biomarkers of PD. The
validation of new tools for clinical trials or practice will take time
and a large number of regulatory requirements need to be consid-
ered. In general, by studying EMG and kinematic characteristics of
PD patients we can increase our understanding of the neuromuscu-
lar dysfunction in PD.
On the basis of the promising results further research and clini-
cal studies are suggested for evaluating the sensitivities and speci-
ficities of the developed methods in various groups of patients. The
research that was presented in this thesis continues by analyzing
the signal characteristics of PD patients in the pre-clinical phase
of the disease, by comparing the signal characteristics between PD
patients and ET patients and by testing the sensitivity of the mea-
surements during the adjustment of optimal DBS settings. It must
be noted that the use of the analysis approaches is not restricted to
PD. Other applications of the methods could include physiological
or disease-based processes that lead to MU synchronization.
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Saara Rissanen
Feature Extraction Methods for 
Surface Electromyography and 
Kinematic Measurements in 
Quantifying Motor Symptoms 
of Parkinson’s Disease
Parkinson’s disease (PD) is a neu-
rodegenerative disease that is char-
acterized by motor symptoms. The 
symptoms are currently quantified 
subjectively. In this thesis, novel ap-
proaches were developed for quanti-
fying objectively the neuromuscular 
and motor function in PD by using 
surface electromyography and kin-
ematic measurements. The results 
demonstrate the potential usability 
of these measurements and the de-
veloped feature extraction methods 
in quantifying motor symptoms of 
PD and the effects of treatment. 
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